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a b s t r a c t
The ten Berge model (or ‘‘toxic load’’ model) is often used to estimate the acute toxicity for varying com-
binations of inhaled concentration and duration. Expressed as Cn  t = toxic load (TL), TLs are assumed
constant for various combinations of concentration (C) and time (t). Experimental data in a recent acute
inhalation study of rats exposed to time-varying concentrations of hydrogen cyanide (HCN) supported
the validity of the toxic load model except under very brief, discontinuous, high concentration exposures.
In the present investigation, experiments were conducted to extend the evaluation of the applicable
domain of the model for acute lethality of HCN in the rat (cumulative exposure range of 2900–
11,000 ppmmin). The lethality of HCN over very short (<5 min) durations of high concentrations did
not conform to the toxic load model. A value of n = 1.57 was determined for uninterrupted exposures
P5 min. For 30-min exposures, the presence or absence of a gap between two exposure pulses of differ-
ent concentrations, the relative duration, relative height, and the ordering of the pulses (low then high, vs.
high then low) did not appear to have a meaningful impact on the toxic load required for median
lethality.
 2015 Elsevier Inc. All rights reserved.
1. Introduction
To address the need to estimate the acute toxicity of vapors and
gases of potentially exposed individuals for varying combinations
of concentration and duration, the ten Berge model (ten Berge
and van Heemst, 1983; ten Berge et al., 1986), also known as the
toxic load model (Ride, 1995; Sommerville et al., 2006), is often
used. The ten Berge/toxic load model is expressed as Cn  t = k,
where ‘‘n’’, the toxic load exponent, and ‘‘k’’, the toxic load, are con-
stant for various combinations of concentration (C) and time (t).
These parameters, n and k, are typically derived from toxicity stud-
ies where animals were exposed to different concentrations of test
chemicals for specified exposure durations. When n = 1, this equa-
tion simplifies to C  t = k and is known as Haber’s Rule (Haber,
1924; Witschi, 1999). The toxic load model is used in the U.S. for
military operational risk assessments (Department of Defense,
2005; Sommerville et al., 2010) that inform strategic planning for
response actions and in civilian applications such as the develop-
ment of Acute Exposure Guidelines (National Research Council,
2001). Tabulated values for n and k are available for a wide range
of chemicals and endpoints from multiple sources (Health and
Safety Executive, 2015; Mannan, 2005).
A theoretical basis for the toxic load model and its extension
from the constant-concentration exposures typically found in the
laboratory to the time-varying exposures encountered in a typical
release scenario has had limited development until relatively
recently (Rhomberg, 2009; Kaplan, 2009; Pauluhn, 2015), perhaps
in part due to the paucity of relevant experimental data that could
be used to test such theories. Because no experimental studies had
systematically investigated acute toxicity under nonconstant con-
centration vs. time profiles, a case study was conducted using
hydrogen cyanide (HCN) as the test chemical and acute lethality
in rats as the endpoint (Sweeney et al., 2014). In that study, rats
were exposed to either constant concentrations of HCN or
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experienced ‘‘pulsed’’ exposures consisting of two different con-
centrations of HCN (2:1 or 5:1 ratio), with or without a ‘‘gap’’
between pulses (30% of the total exposure duration), with a total
duration (exposure plus gap, if applicable) of 5 or 30 min. Most
of the tested scenarios (6/8) were found to conform to the toxicity
expected based on the toxic load model; the two exceptions were
very brief, high concentration, discontinuous exposures (exposures
with ‘‘gaps’’) where higher-than expected HCN concentrations
were required to produce equivalent lethality. If the recovery time
afforded by the gap was protective in a short (5-min) exposure, it
would be expected to be protective in a longer exposure as well
(30 min) but was not. We speculated that during very brief pulses
(1.75 min), some rats were able to reduce their systemic exposure
via breath-holding, an adaptation that could not be sustained dur-
ing longer exposure durations. Despite the extensive application of
the toxic load/ten Berge model, the findings of Sweeney et al.
(2014) provide the first known experimental support for the model
under non-constant concentration exposure conditions. The appli-
cability of these findings to other chemicals is unknown, but is
most likely to hold for other compounds that act by similar modes
of action or on similar time scales.
In the present investigation, additional experiments were
designed and conducted to extend the evaluation of the applicable
domain of the toxic load model for the case of acute lethality of
HCN in the rat. Additional concentration vs. time profiles were
evaluated to clarify the toxicity of brief exposures and to determine
if the order (high-then-low, vs. low-then-high) or the relative dura-
tions of the pulses has an impact on lethality.
2. Materials and methods
2.1. Selection of test chemical
The current experiments and analyses build on previous efforts
described in Sweeney et al. (2014). The aim of both the current and
previous work was to test the validity of the toxic load model by
means of a case study or series of case studies rather than being
driven by a desire to understand the test chemical itself. HCN
was selected as the test chemical largely due to the necessity to
select a chemical, species (rat), and endpoint (lethality) for which
the toxic load exponent was known to differ from 1 (Department
of Defense, 2005; National Research Council, 2002). The ability to
readily and consistently generate the targeted vapor concentra-
tions was considered advantageous from the standpoint of
experimental logistics. HCN also demonstrates consistent toxicity
among species, binding to cytochrome oxidase and thereby rever-
sibly preventing oxygen utilization in sensitive tissues such as the
brain (National Research Council, 2002, 2008).
2.2. Overview of experimental design
Laboratory rats were exposed to an atmosphere containing HCN
using a nose-only exposure system. A variety of C  t profiles were
generated in order to discern the impact (or lack thereof) of the fol-
lowing factors on HCN lethality: constant concentration exposure
vs. variable concentration exposure (i.e., two pulses with different
concentrations), the ordering of the height of the two pulses, the
relative widths of the pulses, the presence or absence of a gap
between the two pulses, and the total duration of the test (expo-
sure durations plus gap). The height ordering was reversed from
what was tested in a prior series of exposures (high concentration
followed by low concentration in Sweeney et al., 2014). Conflicting
findings on the importance of a ‘‘gap’’ were previously identified in
5-min vs. 30-min exposures, so an intermediate exposure duration
(10-min) was tested in this series. Relative pulse duration was also
varied to test the toxic load model under an additional parameter
and to create more realistic C  t profiles.
Three baseline (conventional) profiles as well as 8 non-constant
(nonconventional) exposure profiles were chosen to further inves-
tigate the applicable domain of the toxic load model, with respect
to acute HCN lethality in rats. A total of 60 trials were conducted
(10 rats per trial). The baseline profiles consisted of exposures of
2.33, 10, or 30 min in duration to a constant concentration of
HCN. The non-constant test profiles were 10 or 30 min in duration,
with either two pulses of equal duration or two pulses at a dura-
tion ratio of 1:2. Pulse 2 concentrations were set at a fixed multiple
of the initial concentration (5-fold higher). Gaps between pulses
were either 0 min (no gap) or 30% of the total duration (i.e.,
3 min or 9 min). The C  t profiles for this series are depicted in
Fig. 1.
As in Sweeney et al. (2014), the study design (Fig. 1) consisted
of baseline exposures (no change in concentration over time)
(Profiles 1, 6, and 11) and the investigation of three tested factors
affecting the shape of the C  t profile using a factorial design
(Profiles 2–5 and 7–10). The current Profiles 8 and 10 provide mir-
ror images to exposures conducted in Phase 1 (Phase 1 Profiles 8
and 10, respectively), facilitating a direct comparison of low–high
vs. high–low ordering on pulse height. For each profile, with the
exception of Profile 6, at least 4 exposure concentrations were test-
ed (see Appendix A), which included trials approximating the
median lethal concentration (LC50) plus additional concentrations
selected to provide coverage of a dose–response range, ideally with
response rates neither 0% nor 100%.
2.3. Animal exposures and monitoring
The animal protocol was approved by the Wright–Patterson Air
Force Base (WPAFB) Institutional Animal Care and Use Committee
and the Air Force Surgeon General’s office. A total of 600 male
Sprague–Dawley (Rattus norvegicus) rats [Crl:CD(SD) BR rats], 5–
6 weeks old, were purchased from Charles River Laboratories
(Wilmington, MA). Rats were maintained in an animal facility
approved by the Association for Assessment and Accreditation of
Laboratory Animal Care International, pair housed prior to expo-
sure, and provided husbandry in accordance with the National
Research Council’s Guide for the Care and Use of Laboratory
Animals. Food and water were made available for all animals ad li-
bitum during periods of non-exposure. Rats were quarantined and
acclimated to the facility for 10 days. During quarantine and accli-
mation periods the rats were pair housed. Following release from
quarantine, all animals were weighed. This weight was used to sort
the rats to their prospective exposure group (10 rats per exposure).
For a given shipment (lot number) of animals, the heaviest were
assigned to the first exposure group, followed by the next heaviest
animals to the second exposure group, and so on so that differ-
ences in weight among groups tested over a time span of up to
4 days would be minimized. The lightest animals from a given
shipment were assigned to the final exposure groups. When more
than one exposure was planned for a single study day, the animals
were redistributed evenly by weight among the two or three expo-
sures for that day. Due to the span of time over which the expo-
sures were to be carried out, animals were ordered in batches
(each batch corresponded to 1 week of testing) so that the animals
were similar in age and weight at exposure. The sorting process
and multiple batches yielded consistent body weights throughout
the study.
Animals were exposed 1 time via nose-only inhalation
(described below). Acclimation to the nose-only tubes was not
done prior to the exposure day, due to the short duration of the
exposures (a single 2.33–30 min exposure). Tube acclimation on
the exposure day involved placing each of the animals in an open
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nose-only tube on a laboratory counter top for 30 min prior to the
initiation of HCN exposures. Time of death and appearance of sev-
ere effects were monitored and recorded when possible during
exposure, for 1 h following exposure, and during a 24-h post-
exposure observation period. Following exposure, rats were singly
housed to facilitate observations in the post-exposure observation
Fig. 1. Graphical depiction of C vs. t profiles of median lethal toxic exposures for inhaled HCN in male Sprague–Dawley rats. Median lethality concentrations were determined
by benchmark dose analysis of 4–9 different exposures of 10 rats per profile (Table 3).
L.M. Sweeney et al. / Regulatory Toxicology and Pharmacology 71 (2015) 571–584 573
period. Surviving animals were returned to the Vivarium after
exposures and a 1-h post-exposure observation period. Rats sur-
viving the exposures were periodically monitored (twice daily)
by vivarium staff and by study staff at approximately 24 h post-
exposure. After the 24 h observation period, surviving rats were
euthanized by carbon dioxide inhalation followed by decapitation
using a guillotine.
2.4. Test chemical
The rats were exposed to a mix of HCN with 21% oxygen, bal-
ance nitrogen from a cylinder diluted by clean breathing air to
attain the desired concentration. The dilution and clean control
air for the exposure system was supplied by an air compressor
and filtered for oils, organics, and particulates by a compressed
breathing air purification system (Model No.: RP050, MST Inc.,
Hicksville, OH). Five cylinders of HCN/oxygen/nitrogen mix expo-
sure gas manufactured by Custom Gas Solutions (Durham, NC)
were obtained from Weiler Welding (Moraine, OH); one at
1000 ppm, two at 2000 ppm, and two at 5000 ppm HCN concentra-
tion. All of the gas cylinders came with an analytical report that
certified the concentrations of the gases to within ±2% with the
gravimetric method of analysis.
2.5. Exposure system, test atmosphere generation, and monitoring
Animals were exposed using a single 12-position Cannon style
nose-only exposure unit (constructed in house) which was previ-
ously described (Sweeney et al., 2013, 2014). Briefly, in order to
produce a clean air gap in the exposure, two parallel dilution sys-
tems were used. Each dilution system was capable of being turned
on or off independently from the other. Temperature, humidity,
and static pressure were monitored in the vented hood containing
the nose-only exposure unit. To the extent possible, the tem-
perature was maintained between 68 and 79 F (20 and 26 C)
and the relative humidity was maintained between 30% and 70%.
The concentration of the HCN gas was measured with a Nicolet
380 Fourier Transform Infrared Spectrometer (FT-IR) (Thermo
Fisher Scientific Inc., Waltham, MA) tuned to a peak at
3339.5 cm1(2994.5 nm). The FT-IR sampled prior to the nose-only
exposure unit at 0.5 L/min from a total system flow of 6.5 L/min.
The FT-IR sampling in this location prevented interference from
moisture, exhaled gasses, and other contaminants. The FT-IR was
zeroed on breathing air at the beginning of each study day. The
FT-IR calibration curve of y = 20511x2 + 3492x was constructed
using seven gas concentrations ranging from 0 to 5000 ppm HCN.
The resulting curve had an R2 of 0.9997. The uniformity of distribu-
tion was determined by measuring the total port distribution (vari-
ability of 7 ports), the temporal distribution (variability within a
single port) and calculating the spatial distribution (variability
between ports). All coefficients of variations were less than 1%.
The average flow rate for the system was 6.49 L/min with a mini-
mum of 6.32 L/min and a maximum of 6.50 L/min. The average
flow rate through the nose-only exposure unit was 6.0 L/min with
a t95% of 10.5 s.
2.6. Study day
A study day was defined as the exposure period from
approximately 8:15 am until 12:00 pm. The animals, pair housed
in their polycarbonate domiciliary cages on a rack, were delivered
from the Vivarium via a closed box delivery truck to the exposure
laboratory around 8:15 am to 8:30 am. After arrival, all animals
were weighed and the first group was loaded into the nose-only
tubes. All other animals were loaded at approximately 30 min prior
to their intended exposure time. The period following the
exposures was used to unload animals from the nose only tubes
and return each animal (singly housed) to a domiciliary cage where
food and water were available ad libitum. No food or water was
available during the exposure. Exposure groups (1–3 per day) were
numbered consecutively from 1 to 60. The exposures were con-
ducted from June 3 through July 2, 2013, from July 29 through
31 July, 2013, and from August 26 through August 29, 2013.
2.7. Selection of exposure concentrations
The first exposures were conducted as single pulses for 2.33 or
10 min (i.e., Profiles 11 and 1, respectively) at target concentrations
approximating estimated LC50 values for young adult male
Sprague–Dawley rats exposed to HCN, as predicted from previous
5- , 15- and 30-min results in this laboratory (Sweeney et al.,
2014). The number of deaths for the 10-min exposure was in the
anticipated range, but no exposure-related deaths were observed
for the 2.33 min exposure; concentrations in subsequent 2.33-
min exposures were increased so that the dose–response relation-
ship could be adequately characterized. In general, initial test con-
centrations for the other exposure profiles were selected to yield
50% lethality based on findings from previous exposures of the
same total duration. Additional target concentrations for a previ-
ously-tested profile were derived using expert judgment, taking
into consideration the observed steepness of the dose response
across profiles, previous results for the profile in question, and
the desired spacing of responses across the dose–response con-
tinuum for the profile in question. Because Profile 6 had previously
been tested, a limited testing regimen (two exposure trials only)
was conducted to confirm the similarity of HCN toxicity between
rats bred 1 year apart; this confirmation was deemed necessary
because the previous HCN lethality results in this laboratory had
differed from those in the literature (Sweeney et al., 2014).
2.8. Dose–response analysis
In order to derive the best estimates of dose (concentra-
tion  time) producing 20% and 50% lethal responses (LCt20 and
LCt50), results for each profile (Appendix A) were evaluated using
the U.S. Environmental Protection Agency’s (U.S. EPA) Benchmark
Dose Software (BMDS, version 2.2.0) with the BMDS Wizard (ver-
sion 1.6.1, ICF International, Durham, NC). Dose was expressed as
Cavg  t (in ppm min). The dose for all the animals in a single trial
was computed using the total exposure time regardless of the esti-
mated time of death, consistent with the derivation population-
level outcomes. The following dichotomous dose–response models
were tested: Logistic, LogLogistic, Probit, LogProbit, Weibull,
Quantal-Linear, Multistage, Gamma, and Dichotomous-Hill. In all
cases, a background response rate of zero was assumed. Outputs
from the dose–response analysis included a graphical presentation
of the dose–response relationship, an estimate of the goodness-of-
fit, the best estimate of the dose (concentration  time) producing
a 50% lethal response (LCt50), the 97.5th percent lower confidence
limit on the LCt50 (LCt50LCL), and standardized residual errors. A
value for the upper confidence limit is not provided by the
BMDS. Thus, the upper limit was estimated by assuming that the
uncertainty distribution is symmetrical; the range between the
97.5th percent lower and upper confidence limits was therefore
assumed to encompass the 95th percent confidence limits on the
LCt50. The best-fitting model among those with an acceptable fit
was identified using Akaike’s Information Criterion, unless visual
inspection identified poor fit in the region of interest (the bench-
mark response rate) (U.S. EPA, 2012). Outputs for 20% response
rates were likewise determined. The goodness-of-fit was charac-
terized by a p-value. In the event of p < 0.10 (a poor fit, per U.S.
EPA, 2012), U.S. EPA recommended that modelers should first
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consider the possibility of problems with the data, rather than
problems with the model fitting process. For this analysis the
datum with the highest standardized residual error was typically
eliminated and the analysis repeated with the reduced data set.
If necessary, a second datum with the highest remaining residual
error was eliminated to see if the data could be reduced to a data
set yielding an acceptable p-value; exceptions are described below
under Section 3.4. The analysis was interpreted as identifying an
outlier if the resulting LCt50 confidence limits of the reduced data
set were narrower than for the full data set. Because the findings
for 30-min constant concentration exposures in this study series
were consistent with data collected 1 year earlier (Sweeney
et al., 2014), results from both phases were combined for analysis
of Profile 6.
2.9. Estimation of the toxic load exponent
A revised estimate of the toxic load exponent (‘‘n’’ in Cn  t) for
HCN was derived in a manner similar to that used for the previous
estimate (Sweeney et al., 2014). The toxic load equation, Cn  t = k
(where k is a constant for a specific response level), was applied to
the median lethal concentration, so (LC50)n  t = TL50. Taking the
logarithm of this equation and rearranging:
logðtÞ ¼ logðTL50Þ  n logðLC50Þ
The logarithms of the LC50 estimates and durations for 2.33-, 5-,
10-, 15- and 30-min constant concentration exposures (Phase 1
and Phase 2 Profiles 1, 6, and 11 in Sweeney et al., 2014 and current
data) were used as inputs to a linear regression to derive a TL50 (the
intercept) and n (the slope, multiplied by 1). The resulting toxic
load exponent was substantially different from that determined
previously based only on 5, 15, and 30-min exposures; as discussed
below, the 2.33-min data were excluded from the final determina-
tion of the revised toxic load exponent (see Section 3.5).
2.10. Comparisons of lethal toxic loads based on concentration vs. time
profiles
As previously described in Sweeney et al. (2014), two general
expressions for the TL received during exposure to an airborne che-
mical (used for risk assessment applications), as a function of time,
are:
TL ¼
Z tall
0
½CðtÞn dt or TL ¼
Xp
j¼1
Cnj  sj
where, C(t) = the instantaneous agent concentration as a function of
time (ppm or mg/m3), tall = the total exposure duration (minutes),
n = the toxic load exponent (dimensionless), Cj = the mean concen-
tration over interval j (ppm or mg/m3), sj = the duration of interval
j (minutes), p = the number of integration intervals (dimensionless).
TLswere computed both for an assumed perfect pulsed exposure
using piecewise (PW) concentrations (TLPW = C1n  t1 + C2n  t2)
(same as p = 3 integration intervals) and the duration-averaged
(DA) concentration (TLDA = Cavgn (t1 + tgap + t2); where
Cavg = ([C1  t1 + C2  t2]/[t1 + tgap + t2]) (p = 1 integration interval).
TL were calculated for 50% and 20% lethality and their 95% confi-
dence limits. For TL50,
TL50;DA ¼ LCt50t
 n
 t
and
TL50;PW ¼ TL50;DA 
DR þ 1CRn
 
DR þ 1CR
 n  1þ DR1 f
 ðn1Þ
where f = gap duration (fraction of total duration; 0 or 0.3),
CR = concentration ratio for pulses (C1/C2; 1/5 for all non-constant
profiles, 1 for Profiles 1, 6, and 11), and DR = duration ratio for puls-
es (t1/t2; 1 or 2). The equation for TL50,DA is from the definition;
derivation of the algebraic relationship between TL50,DA and
TL50,PW is provided as Appendix B. TLPW is always greater than or
equal to TLDA for the same concentration–time profile. The use of
square-wave profiles (Fig. 1) establishes an exact mathematical
relationship between the definitions of TLDA and TLPW, which does
not exist in real-life exposure scenarios.
Statistical analyses of TL50 estimates were conducted using
SigmaPlot (version 12.5); a p value of <0.05 was used to establish
statistically-significant differences. Groups to be compared were
tested for normality using the Shapiro–Wilk test. Normally dis-
tributed data were tested for equality of variance; if variances were
found to be equal, the group comparison was made using the 2-
tailed t-test. If the groups failed the Shapiro–Wilk test (i.e., data
were determined not to be normally distributed) or found to have
unequal variance, they were compared using the Mann–Whitney
rank sum test for the comparison of medians. Comparisons were
made between the following groups based on the design criteria:
baseline vs. pulsed; short duration vs. long duration; continuous
vs. discontinuous; small vs. large pulse height difference, pulse
duration ratio (equal or unequal), and pulse height order (high
then low vs. low then high).
3. Results and discussion
3.1. Experimental and operating conditions
The environmental and operating conditions for each exposure
are reported in Supplementary Data Table S-1. Overall, the envi-
ronmental conditions were very consistent among the 60 expo-
sures, and within the specified ranges, with the exception of
humidity. Humidity slightly exceeded 70% (70.4% and 70.5%) for
two exposures. The reported achieved concentrations represent
the averages of the last 2 min of each pulse and were within 1%
of the target concentrations (Table A-1).
3.2. Test animals
The rats used in these experiments ranged in age from 53–
56 days and weighed between 211.8 and 320.0 g at exposure.
Individual animal data (age, weight, exposure, exposure outcome)
and age and weight summaries by profile are provided in
Supplementary Data (Tables S-2 and S-3). Rat body weights were
well balanced both across and within the 11 profiles. Among the
60 total trials (10 rats per trial), the lowest average body weight
was 242.6 g (a trial of Profile 10), and the highest average weight
was 279.0 g (a trial of Profile 7), roughly a 15% difference, so the
60 trials span a limited range. When aggregated across trials, the
profile with (on average) the heaviest rats (Profile 2), was conduct-
ed with rats averaging 269.7 g (standard deviation 12.8 g), while
the profile with lightest rats used rats averaging 257.8 g (standard
deviation 17.7 g), so across the 11 profiles, the minimum and max-
imum of the average body weights differ by only 5%. In the profile
with the largest variability among trials (Profile 7), average
weights had a mean of 265.5 g and standard deviation of 14 g,
for a coefficient of variation of 5% (Table S-3).
3.3. Exposure outcomes summary
Out of 600 exposed rats, approximately 56% died within 24 h
post-exposure and their deaths were attributed to HCN exposure
(Table 1). All but two of those deaths occurred either during
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exposure or during the post-exposure period (5 min) between the
cessation of HCN exposure and removal of the rats from the expo-
sure tower (removal of the animals by study personnel was
delayed to allow for the clearance of HCN from the exposure tower
prior to equipment and animal handling). Both of those two deaths
occurred during the 1 h period after exposure designated for close
observation of the animals. An additional post-exposure death was
observed 3 days after exposure; the cause was undetermined but
for dose–response purposes was not attributed to HCN as the rat
appeared normal at the 1 h and 24-h post-exposure observation
points and subsequent evaluations. Many of the rats that survived
the exposure initially displayed clinical signs such as labored
breathing, impaired/uncoordinated movement, and tremors/
twitching (Table 2). With the exception of the two deaths noted
above, most appeared fully recovered within 1 h and all survivors
appeared fully recovered within 24 h.
3.4. Dose–response analysis
The benchmark dose modeling results are summarized Table 3.
Our preference was to identify single, best LCt values and confi-
dence limits when defensible (high quality model fit derived from
consistent, logical data) or a range of likely values if a single, best
LCt value could not be identified with confidence. For 6 of the 11
profiles, dose–response analyses using all of the trials yielded good
to excellent fits (p = 0.40 to 0.89 for Profiles 1, 2, 3, 5, 6, and 8). Two
additional profiles (Profiles 10 and 11) each had one trial that was
readily identified as an outlier, and the exclusion of the outlier
caused a substantial improvement in the p-value associated with
the best fit models (from p < 0.1 to p = 0.64 and 0.78 for profiles
10 and 11, respectively). Three profiles (Profiles 4, 7, and 9) were
more difficult to evaluate and warrant further explanation.
The outcomes from Profile 4 were unusually inconsistent
(Appendix A, Table A-1). When all of the individual trials were
included, the best fit p-value was 0.0029. Two trials of this profile
with cumulative doses (C  t) that differed by 0.2% produced very
different outcomes: 3 and 10 deaths out of 10 exposed animals per
trial. When these two trials were combined (13 deaths out of 20
exposed), one model produced an acceptable p value (p = 0.139),
but the results were not usable because lower confidence limits
Table 1
Rat deaths attributed to hydrogen cyanide inhalation.
Profile Number of
animals
exposed
Number surviving
24 h
postexposure
period
Timing of deaths
During
exposure
0–1 h
post-
exposure
1–24 h
post-
exposure
1 50 22 28 0 0
2 40 17 23 0 0
3 40 15 25 0 0
4 80 26 54 0 0
5 40 16 24 0 0
6 20 11 9 0 0
7 60 32 28 0 0
8 40 21 19 0 0
9a 70 36 34 0 0
10 90 36 53 1 0
11 70 34 35 1 0
a Total deaths indicates deaths within 24 h of exposure. One rat from Profile 9
died after the 24 h post-exposure period (died at 72.5 h post-exposure, cause
undetermined) and is not included in that total.
Table 2
Initial clinical signs observed in rats surviving hydrogen cyanide exposure.
Clinical signa Profile
1 2 3 4 5 6 7 8 9 10 11
Lethargy 1 5 0 3 0 1 7 8 2 7 0
Labored breathing 20 16 11 20 11 8 27 18 30 28 16
Gasping 0 0 2 4 4 1 0 0 1 2 4
Tremors/twitching 17 14 15 22 13 7 24 11 33 19 16
Impaired
Movement/
uncoordinated
19 15 13 20 9 8 24 16 25 20 12
Inability to remain
upright
0 1 1 3 5 0 0 0 3 2 8
Bloody mouth,
nose, and/or
eyes
0 1 1 2 3 0 6 1 3 8 5
Unresponsive 0 0 1 3 5 0 0 0 2 1 7
Total survivors
observed
22 17 15 26 16 11 32 21 36 36 34
a Reflects only the initial postexposure observations; more than one sign may
have been observed per rat.
Table 3
Calculated lethality of inhaled HCN in male Sprague–Dawley rats (Phase 2).
Exposure
duration
Profile LCt50 (95% confidence interval)
(ppmmin)
LCt50
LCt50LCL
LCt20 (95% confidence interval)
(ppmmin)
LCt20
LCt20LCL
Model Model Fit p-
value
10 min 1 6049 (5414–6684) 1.12 4919 (3670–6168) 1.34 Gamma 0.88
2 6234 (5462–7006) 1.14 5070 (3521–6619) 1.44 Gamma 0.89
3 6016 (5047–6985) 1.19 4893 (2995–6791) 1.63 Gamma 0.41
4a,b 6329 (5099–7559) 1.24 4639 (2515–6763) 1.84 Weibull 0.60
4a,c 5733 (4849–6625) 1.18 3185 (2204–4166) 1.49 Probit 0.25
5 5972 (5283–6661) 1.13 4856 (3591–6121) 1.35 Gamma 0.75
30 min 6d 7851 (7287–8415) 1.08 6384 (5769–6999) 1.11 Gamma 0.89
7b 8205 (7090–9320) 1.16 6373 (3463–9283) 1.84 Weibull 0.46
7c 6703 (4570–8836) 1.47 3382 (1471–5293) 2.30 Weibull 0.56
7e 8132 (6583–9681) 1.24 4366 (3281–5452) 1.33 Logistic 0.22
8 7636 (6833–8439) 1.12 6210 (4998–7422) 1.24 Gamma 0.40
9c 7799 (7054–8544) 1.10 6123 (3588–8658) 1.71 Dichotomous-
Hill
0.16
10c 6172 (5667–6677) 1.09 5019 (4273–5765) 1.17 Gamma 0.64
2.33 min 11c 4460 (4136–4784) 1.08 3911 (3438–4384) 1.14 Log-Probit 0.78
Shaded profiles 1, 6 and 11 are constant concentration exposures for 10, 30 and 2.33 min, respectively (see Fig. 1 for depiction of profiles). For individual trial results and
identification of trials dropped for dose–response analysis, see Appendix A, Table A-1.
a Two trials with roughly the same concentrations but very different outcomes (3/10 and 10/10) were combined.
b Two trials dropped.
c One trial dropped.
d Previous data from the same laboratory (Sweeney et al., 2014) were combined with data from two additional trials.
e All data included in estimation of LCt values, but these values were not used in toxic load model assessment.
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on the LCt values could not be computed. In reviewing the estimat-
ed times of death for these two trials and the excluded trial, no
unusual patterns were noted in the timing of the deaths, relative
to other trials for this profile (data not shown). When the trial with
the highest standardized residual error was removed, fit improved
to p = 0.25; removal of a second trial improved fit to p = 0.60, but
slightly increased the LCt50/LCt50LCL ratio.
It was difficult to discern which point or points should be
excluded from Profile 7 to achieve an improved fit (as compared
to including all of the data, which yielded acceptable (p > 0.1) but
relatively poor quality fits (p = 0.17 to 0.22 in usable models). If a
single datum was eliminated, fit improved, but the LCt50/LCt50LCL
ratio was unusually high and the LCt20 was not consistent with that
observed for other 30-min exposures. If two points were to be
eliminated, it appeared to make the most sense not to include
the first point eliminated, but instead to remove two different
points; the overall quality of the fit (p value) decreased (from
0.56 to 0.46), but the confidence in the LCt50 estimate improved.
One of the excluded trials (69.9 ppm for 20 min, 355.7 ppm for
10 min) included two deaths identified early in the second pulse
(21:20 and 22:36), the earliest identified deaths for this profile,
so it is possible that this trial happened to have two unusually sus-
ceptible rats.
Similar to Profile 7, inclusion of all of the Profile 9 data did not
produce acceptable model fits (p < 0.1), but it was not clear which
data should be excluded. Exclusion of one data point (two differ-
ent points were tested) produced improved fits to the data
(p = 0.13 and 0.16), but the possibility of further improvement
was explored. Various combinations of two data points were
deleted; some analyses yielded no acceptable model fits; the
results of alternative analyses with two data points dropped did
not substantially improve the fit or alter the BMD (data not
shown).
The alternative LCt estimates were carried forward into the TL
computations (see below) so that the impact (if any) of the choice
of which trials to exclude could be assessed.
3.5. Determination of the toxic load exponent
LC50 values for the 2.33-, 5-, 10-, 15, and 30-min constant con-
centration exposures conducted in this laboratory (data of
Sweeney et al., 2014 and current data) were initially used to derive
a new estimate of the toxic load exponent (Fig. 2). When all 5 expo-
sure durations were used, the toxic load exponent decreased to
1.31, and the 95% confidence limits for the 5-min TL50 were below
the range identified for the other 4 durations (data not shown). If
only the 2.33- and 5-min data are considered (the two points fur-
thest to the right in Fig. 2), HCN lethality approximately follows
Haber’s Rule (that is, the toxic load exponent is approximately 1),
however, none of the LC50 value estimates for longer exposures
are consistent with Haber’s Rule. When the 2.33-min data were
excluded, the log t vs. log LC50 linear regression had an r2 of 0.97
and the estimated toxic load exponent was 1.57 (1  slope), simi-
lar to the value of 1.66 determined in this laboratory from the 5, 15,
and 30-min data alone (Sweeney et al., 2014). The median lethal
toxic load estimate was 194  103 ppm1.57 min. Using the toxic
load exponent of 1.57, the TL50 estimates for 5-, 10-, 15-, and 30-
min constant concentration exposures (Phase 1 Profile 1, Phase 2
Profile 1, Phase 1 Profile 11, and Phase 2, Profile 6, respectively)
had overlapping 95% confidence ranges (Fig. 3). A toxic load expo-
nent of 1.57 rather than 1.31 was used in all subsequent TL50 cal-
culations due to the likelihood physiological adaptations were
occurring during the shortest (2.33-min) exposures (Pauluhn,
2006). A similar analysis was completed for the LC20 values.
Again, the 2.33-min exposure appeared to be an outlier; a toxic
load exponent of 1.53 was determined from the 5-, 10-, 15-, and
30-min LC20 values.
3.6. Discrimination between alternate methods for computation of the
toxic load
The TL50 values for the present data and revised TL50 values for
the exposures from Phase 1 (Sweeney et al., 2014) were computed
using the piecewise and duration-averaged methods (see above,
Section 2.10). The TL50 and 95% confidence limits for Phase 2
Profile 11 (2.33-min of continuous exposure) were observed to fall
entirely outside the 95% confidence limits derived for the other
baseline profiles (Fig. 3).
Under the duration-averaged approach, Phase 2 Profile 10 was
the only time-varying profile that appeared not to conform to the
toxic load model (Fig. 3). When the piecewise approach was used,
the profiles with a brief pulse of exposure (less than 5 min; Ph1 to
Ph2P5) appeared not to conform to the toxic load model (minimal
overlap between the baseline TL range and the TL ranges of these
profiles). The lack of conformation to the toxic load model held
true for both the 2.33-min continuous exposure (Ph2P11) and
the 5 or 10 min exposures with a gap (Phases 1 and 2, Profiles 4
and 5). In contrast, the piecewise TLs for non-constant profiles
tended to be slightly elevated and duration average profiles slight-
ly lower relative to the 5- to 30-min constant profile TLs, but both
approaches were predominantly within the range established by
the baseline TLs.
The 2.33-min HCN exposure clearly does not conform to the
toxic load model established by the 5–30 min data (Fig. 3). It fol-
lows logically that pulsed exposures that incorporate isolated puls-
es of similarly brief duration (i.e., exposure Profiles 4 and 5 from
both phases) would be likely to deviate from the toxic load model
in a similar manner, while other exposures (isolated pulses or con-
tinuous exposure P5 min) would be expect to be in agreement
with the model. When the best estimates for the piecewise TLs
were used (that is, the alternative values for Phase 2, Profiles 4,
7, and 9 are omitted), all 5 ‘‘short’’ TLs were outside the bounds
established by the constant exposures, with 13 of 16 longer expo-
sures within the bounds. When similar comparisons were made for
the duration averaged exposures, somewhat better agreement was
found for the longer exposures (15/16 within the bounds), but
duration averaging was less likely to discriminate that short pulses
do not conform (3/5 outside the bounds, 2/4 non-constant expo-
sures outside the bounds). That is to say, the piecewise approach
does a substantially better job at identifying the ‘‘true negatives’’
Fig. 2. Acute lethality (LC50 in ppm, t in minutes) of inhaled hydrogen cyanide in
male Sprague–Dawley rats (current data and Sweeney et al., 2014, mean ± 95%
confidence limits). Diamonds indicate data used to derive the regression line (solid
line; slope = 1.57); the square indicates 2.33-min LC50, which was excluded from
this analysis. The dashed line indicates predictions of LC50 values associated
extrapolated from the 2.33-min LC50 to other exposure durations if HCN lethality
conformed to Haber’s Law (slope = 1).
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than the duration approach, whereas the duration averaging
approach does a slightly better job at identifying the ‘‘true posi-
tives’’. Therefore it was concluded that, on the whole, the piecewise
TL computations capture the difference between exposure profiles
slightly better than the duration-averaged approach. However,
since the data were not conclusive, both the piecewise and dura-
tion averaged approaches were used for comparisons among pro-
files. The use of alterative TL values for Phase 2 Profiles 4 and 7
(Ph2P4a and Ph2P7a) would have no impact on these conclusions
about the two approaches.
3.7. Comparisons of median lethal toxic loads based on concentration
vs. time profiles
The comparisons of TL50s for C vs. t profiles grouped by com-
mon characteristics are summarized in Table 4; eligible profiles
were limited to those with no pulse less than 5 min due to
concerns about deviations from the toxic load model for short,
isolated pulses. Phase 1 exposures (Sweeney et al., 2014, summa-
rized in Appendix A, Table A-2) were included if they met the
eligibility criteria; revised piecewise Phase 1 TLs were calculated
using a toxic load exponent of 1.57. Comparisons were made
based only on the central tendency estimates for TLs and thus
do not account for the uncertainty in the lethality estimates for
each profile.
3.7.1. Constant vs. pulsed exposures
Constant concentration exposures were compared to pulsed
exposures (Sweeney et al., 2014 Profiles 1 and 11 and current
Profiles 6 and 11 vs. Sweeney et al., 2014 Profiles 7–10 and current
Profiles 3 and 7–10). The difference was found to be marginally
statistically significant (p = 0.047) using piecewise computation,
but not duration averaging. If the most uncertain results (current
Profile 7) were omitted or the alternate results were used, the dif-
ference was no longer statistically significant (p = 0.10 or 0.13,
respectively).
3.7.2. Pulse height order
Exposures where the high concentration pulse preceded the low
concentration pulse were compared to exposures conducted with
the reverse ordering (Sweeney et al., 2014 Profiles 7–10 vs. current
Profiles 3 and 7–10). No statistically significant difference was
identified. Two profiles from the current study (Profiles 8 and 10)
were mirror images of profiles from Sweeney et al. (2014) (also
Profiles number 8 and 10). The current Profile 8, where the low
concentration pulse preceded the high concentration pulse and
there was no gap, had an LCt50 of 7636 ppmmin (95% confidence
interval of 6833–8439 ppmmin) whereas when the pulse height
order was reversed (Sweeney et al., 2014), the LCt50 was
7463 ppmmin (95% confidence interval of 6375–8551 ppmmin).
Thus no difference is apparent for this pair of profiles. For Profile
Fig. 3. Toxic loads computed by the duration averaging approach (TL50DA = unfilled squares) or piecewise method (TL50PW = filled circles); symbols overlap for constant-
concentration exposures and appear as squares surrounding a filled circle. Solid line = toxic load (computed from 5-, 10-, 15-, and 30-min constant concentration exposures);
dashed line = maximum upper and lower confidence limits on the toxic load from the same exposure profiles. X-axis labels indicate Phase 1 (Ph1) (Sweeney et al., 2014) or
Phase 2 (Ph2) (current effort) and the Profile number and are arranged according to increasing duration of continuous exposure (shortest pulses with a gap, vs. longer pulses
with no gap, or 30-min continuous exposure).
Table 4
Comparison of acute TL50s for acute inhalation of HCN by male Sprague–Dawley rats.
Exposure profiles compared Finding
Constant vs. pulsed Limited support for a difference in TL50
valuesa (piecewise)
Pulse height order Not statistically significant
Pulse duration ratio Limited support for a difference in TL50
valuesa (piecewise)
No gap vs. gap Limited support for a difference in TL50
valuesa (duration averaged)
Shorter duration (5–15 min) vs.
longer duration (30 min)
Not statistically significant
Pulse height ratio Not statistically significant
a Statistically significant at p < 0.05 based on the best-supported interpretation of
the dose–response data (Table 1); but not statistically significant using alternative
interpretations of dose–response data.
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10, the current and prior studies identified LCt50 values (95% con-
fidence interval) of 6172 (5667–6677) ppmmin vs. 7445 (6770–
8119) ppmmin While the lack of overlap in confidence intervals
may suggest a difference in toxicity, it should be noted that the
Profile 10 of Sweeney et al. (2014) had the most uncertain results.
With two of seven trials dropped, the Phase 1 Profile 10 reduced
data set still had a relatively poor fit (p = 0.21); inclusion of the
excluded data sets would have led to lower LCt50 estimates
(5723–6811 ppmmin, depending on the model) but very poor fit
(p = 0.0010–0.0014).
3.7.3. Pulse duration ratio
Exposures where the pulse durations were unequal were com-
pared to the other exposures (current Profiles 7 and 9 vs. all other
eligible profiles). The difference was found to be marginally statis-
tically significant (p = 0.040) using piecewise computation, but not
duration averaging. The two profiles with unequal pulse durations
had the most uncertain dose–response analysis results in the cur-
rent investigation; if the alternate results were used, the difference
was no longer statistically significant (p = 0.36).
3.7.4. Gap vs. no gap
Exposures that included a gap of 30% of the total exposure dura-
tion were compared to those that did not (Sweeney et al., 2014
Profiles1, 7, 8, and 11 and current Profiles 1, 3, 6, 7, 8 vs.
Sweeney et al., 2014 Profiles 9 and 10 and current profiles 9 and
10). No statistically significant difference was found using a piece-
wise approach. A marginally statistically significant difference was
found using the duration averaged approach (p = 0.0416) that was
no longer significant if the alternative TL for the current Profile 9
was used.
3.7.5. Shorter vs. longer duration
Toxic loads for shorter (5, 10 or 15 min) and longer (30 min)
exposures were compared (Sweeney et al., 2014 Profiles 1 and 11
and current profiles 1 and 3 vs. Sweeney et al., 2014 Profiles 7–
10 and current Profiles 6–10). No statistically significant difference
was identified.
3.7.6. Pulse height ratio
Exposures with a low pulse-height ratio (i.e., constant
exposures or a 2:1 ratio) did not have TL50 values that differed
significantly from exposures with a larger pulse height ratio
(5:1). This comparison was based on Sweeney et al. (2014)
Profiles 1, 7, 9, and 11 and the current profiles 1 and 6 vs.
Sweeney et al. (2014) Profiles 8 and 10 and the current Profiles 3
and 7–10.
3.7.7. TL20 results
A parallel analysis was conducted for the TL20 values. No statis-
tically significant differences were found between constant and
nonconstant exposures (data not shown). It should be noted, how-
ever, that the uncertainties associated with the TL20 analysis are
larger, however, because the experiments were designed to pro-
vide the more confidence in median lethal concentrations than
the lower range of the dose–response curve.
4. Conclusions
Prior to the conduct of this study, the apparent protective effect
of a gap during the 5-min exposure (Sweeney et al., 2014) was
hypothesized to be due to a compensatory behavior (e.g., breath
holding or something similar) that can only be sustained during
a short exposure (i.e., less than 5 min). By testing a shorter
constant-concentration exposure (current Profile 11, 2.33 min)
and two different pulse widths, we sought to more finely discern
the maximal duration for the compensatory behavior. The LCt50
for the 2.33-min exposure exceed that of the 5-min exposure, an
observation that indicates behavior inconsistent with a toxic load
exponent >1. Differences between the toxic load model and the
computed TLs for Phase 2 Profiles 2, 4, and 5 further suggest that
exposure profiles with pulses as long as 3.5 min may not conform
to the toxic load model due to pulse duration alone, independent of
other exposure profile characteristics. Taken together, these find-
ings support that physiological compensation, likely via breath
holding in the rodent subjects, is a confounding factor in very short
exposure toxicity estimation. Therefore, the 15 and 30-min expo-
sure profiles from Phase 1 (Sweeney et al., 2014, Profiles 1 and
6–11), and Phase 2 Profiles 1, 3, and 6–11 were deemed to be the
best basis for evaluating the impact of other factors (e.g., gaps,
pulse height ratio, pulse duration ratio) on computed TLs, and thus
for evaluating the validity/limits of the TL model for non-constant
exposure profiles more consistent with real world scenarios.
The 30-min piecewise TLs from non-constant exposures from
both Phase 1 (Sweeney et al., 2014) and Phase 2 were fairly consis-
tently (but not dramatically) higher than the baseline TL. It should
be noted that the ratio of the piecewise TL to the duration-
averaged TL varies among profiles and is fixed based on the profile
characteristics (gap duration, pulse duration ratio, pulse concen-
tration ratio) and nature of the chemical (toxic load exponent).
Thus, profiles differ in their inherent capacity to distinguish
between the two computational approaches; the profiles with
greater power in this regard have larger separation between the
computed TLPW and TLDA (Fig. 2). Based on the currently available
data, the superiority of each model can be supported by some
aspects of the findings. For example Phase 2 Profiles 9 and 10 both
have relatively high TLPW/TLPA ratios (i.e. similar power to dis-
criminate between models), but the Phase 2 Profile 9 duration
averages results were more consistent with the toxic load model,
while the Phase 2 Profile 10 results were more consistent with
the piecewise approach. Ideally, future studies would be designed
to maximize the power to discriminate among the models and
reduce uncertainty.
The comparisons between sets of profiles grouped by various
characteristics (e.g., presence of a gap, pulse concentration ratio,
pulse height order) were restricted to profiles with no short, isolat-
ed pulses to reduce the potential for confounding due to breath
holding or other adaptations. These short-term responses are of
questionable significance to humans as rats have been noted to
have increased responsiveness to respiratory irritants due to
increased vagal activity and other rodent-specific defense mechan-
isms (Pauluhn, 2006). These comparisons provided only very limit-
ed support for conditions that might invalidate the toxic load
model: pulsed concentrations in general, vs. constant concentra-
tions, the presence of a gap in the exposure, and differences in
the duration of the pulses. In the latter case, only two profiles have
been tested where the pulse durations were unequal, so the data
were very limited, and the conclusion preliminary. In particular,
the importance of a gap was hard to evaluate because these scenar-
ios appear to produce the most variable data (e.g., two of the three
profiles that presented the greatest challenge for dose–response
analysis contained gaps). A 30% gap in a 30 min exposure produces
a 9 min period with no exposure. To put this gap duration in the
context of clearance, the cyanide half-life in blood of rats orally
dosed with potassium cyanide has been reported as 14 min
(Leuschner et al., 1991) or 38 min (Sousa et al., 2003). Thus, we
conclude that overall, the data were supportive of the validity of
the toxic load model for continuous exposures of rats for 5 min
or more, but some uncertainty remains for exposures with a gap
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and of differing pulse duration. While these conclusions were
developed using a rat model, we anticipate that they would like-
wise be applicable to humans or other species of interest for
similarly fast acting compound. With regard to hydrogen cyanide
in particular, the elimination half-life in exhaled air for humans
was 15.6 ± 3.9 min (Stamyr et al., 2008), similar to the rat blood
cyanide half-life reported by Leuschner et al. (1991), suggesting
the impact of ‘‘gaps’’ of toxicokinetics might be similar. Stamyr
et al. (2014) recently used physiologically based pharmacokinetic
modeling of HCN lethality from human case reports with times
to death ranging from 7 to 60 min to derive a toxic load exponent
of 2.4. This human value is slightly higher than the value of 1.6 for
rats (derived herein) and the value of 2.1 for monkeys derived by
the National Research Council (2002). The similarities of both
half-life and toxic load exponent between rats and humans suggest
the conclusions drawn from the current rat study would be appli-
cable to hydrogen cyanide lethality in humans exposed to varying
C vs. t patterns.
Rhomberg (2009) and Saltzman (1996) both explored the rela-
tionship between exposure concentration and body burden
throughout the time course of an inhalation exposure. Saltzman
(1996) considered fluctuating exposures (sine wave concentra-
tions) and observed that if the air concentration averaging time
was less than 1/4 the biological half-life, the short-term variation
in the exposure has little impact on time course for the body bur-
den, under conditions of first order kinetics. Rhomberg (2009)
found that for exposure durations of less than or equal to one
half-life, body burdens followed Haber’s rule, after 4 or more
half-lives, they were proportional to exposure concentration, and
in the intermediate range, the ten Berge equation (toxic load mod-
el) was a better approximation. Body burden alone is not neces-
sarily a predictor of toxic response, as it does not account for the
balance between damage and repair (Rhomberg, 2009). For rats
given oral doses of cyanogens (at 0.75  LD50), a direct relationship
between blood and tissue cyanide levels and cytochrome oxidase
inhibition was demonstrated, consistent with minimal lag time
for onset and recovery once toxic levels of cyanide have been
reached in tissues (Rao et al., 2013). Nonetheless, the rat hydrogen
cyanide lethality data were consistent with a toxic load exponent
closer to ‘‘1’’ (Haber’s rule) at the shorter times we tested (2.33–
5 min) (Fig. 2), as indicated by Rhomberg (2009) and better
described by the ten Berge equation for longer exposure durations
(2 times the half-life, or 30 min).
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Appendix A
24-h outcomes for each HCN inhalation trial are provided in
Table A-1. Dose–response plots are provided in Figs. A-1 and A-2.
Table A-1
24-h lethality data for HCN inhalation by male Sprague–Dawley rats. (See Fig. 1 for C vs. t profile depictions).
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
10-min profiles
Profile 1
(10-min pulse)
Profile 2
(6.67-min pulse, no gap, 3.33-min pulse)
Profile 3
(5-min pulse, no gap, 5-min pulse)
489.3 ± 1.6 4893.0 2
590.0 ± 4.3 5900.0 4 234.2 ± 1.4/
1175.3 ± 3.8
5479.0 2 183.4 ± 1.2/
899.9 ± 3.0
5416.5 3
642.5 ± 2.4 6425.0 5 265.5 ± 1.4/
1299.7 ± 5.4
6101.3 5 205.1 ± 1.3/
1014.4 ± 3.9
6097.5 6
681.3 ± 2.4 6813.0 8 297.7 ± 1.5/
1442.6 ± 4.3
6793.3 7 261.7 ± 1.3/
1157.6 ± 4.5
7096.5 6
778.0 ± 2.9 7780.0 9 357.6 ± 1.9/
1780.0 ± 6.7
8317.3 9 270.8 ± 1.5/
1331.8 ± 4.9
8013.0 10
Profile 4
(4.67-min pulse, 3-min gap, 2.33 min pulse)
Profile 5
(3.5 min pulse, 3 min gap, 3.5 min pulse)
277.8 ± 1.9/
1368.6 ± 5.6
4489.8 6a
322.7 ± 1.8/
1573.6 ± 4.7
5177.7 3
376.6 ± 1.8/
1847.7 ± 8.7
6068.8 5 273.0 ± 1.4/
1280.4 ± 3.7
5436.9 3
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Table A-2 provides a tabular summary of exposure scenarios and
results from Sweeney et al. (2014).
Appendix B
Derivation of the relationship between two different methods
for computing the toxic load.
By definition:
t1 þ t2 ¼ ð1 f Þ  tall ð1Þ
and
t1 ¼ t2  DR ð2Þ
Therefore by substitution of Eq. (2) into Eq. (1):
t2  DR þ t2 ¼ ð1 f Þ  tall ð3Þ
Rearranging Eq. (1) to solve for t2:
t2 ¼ tall  ð1 f Þ=ð1þ DRÞ ð4Þ
Substituting Eq. (4) into Eq. (2):
t1 ¼ tall  ð1 f Þ  DR=ð1þ DRÞ ð5Þ
By definition:
TL50;DA ¼ ðLCt50=tallÞn  tall ð6Þ
and
TL50;PW ¼ ðC1;50Þn  t1 þ ðC2;50Þn  t2 ð7Þ
Table A-1 (continued)
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
Concentration
(ppm)
Cavg  t
(ppmmin)
Deaths (out of
10)
442.0 ± 1.4/
2177.5 ± 7.1
7143.5 10b 287.6 ± 1.7/
1409.1 ± 4.8
5938.5 5
444.9 ± 4.0/
2178.1 ± 15.2
7158.4 3b 316.5 ± 0.8/
1574.7 ± 5.3
6619.2 6
471.8 ± 2.2/
2331.5 ± 10.3
7641.9 10 a,c 397.0 ± 2.3/
1941.7 ± 6.9
8185.45 10
501.0 ± 2.1/
2474.9 ± 7.9
8112.8 7
566.5 ± 1.8/
2793.3 ± 13.2
9161.4 10
30-min profiles
Profile 6
(30-min pulse)
Profile 7
(20-min pulse, no gap, 10-min pulse)
Profile 8
(15-min pulse, no gap, 15-min pulse)
138.5 ± 2.6 4155 0d
200.8 ± 3.1 6024.0 1d
220.3 ± 1.2 6609.0 2 69.9 ± 0.9/
355.7 ± 1.9
4955.0 4a 62.1 ± 1.0/
314.5 ± 1.5
5649.0 0
226.1 ± 2.4 6783.0 1d 81.2 ± 0.9/
406.8 ± 1.7
5692.0 5a 71.2 ± 0.9/
359.7 ± 1.6
6463.5 4
254.6 ± 2.4 7638.0 6d 91.6 ± 0.9/
455.3 ± 1.7
6385.0 3 94.0 ± 1.1/
472.0 ± 2.0
8490.0 6
273.5 ± 3.5 8205.0 6d 104.8 ± 1.0/
523.9 ± 2.4
7335.0 2c 108.5 ± 1.1/
543.0 ± 2.3
9772.5 9
290.0 ± 2.7 8700.0 7 129.9 ± 1.6/
604.2 ± 2.4
8640.0 6
303.0 ± 2.7 9090.0 8d 141.8 ± 1.1/
693.0 ± 2.5
9766.0 8
Profile 9
(14-min pulse, 9-min gap, 7-min pulse)
Profile 10
(10.5-min pulse, 9-min gap, 10.5-min pulse)
2–1/3-min profile
Profile 11
(2.33-min pulse)
76.8 ± 1.0/
377.5 ± 2.0
4770.2 1
84.3 ± 1.0/
416.3 ± 1.6
5256.3 3
128.0 ± 1.0/
641.8 ± 2.5
6284.6 2 96.6 ± 1.2/
475.5 ± 2.5
6007.1 5 1239.0 ± 5.6 2891.0 0
135.0 ± 1.2/
685.2 ± 11.6
6686.4 2 95.8 ± 1.0/
479.4 ± 1.8
6039.6 6 1597.5 ± 3.92 3727.5 1
144.2 ± 0.9/
722.4 ± 3.3
7075.6 2 108.0 ± 1.1/
544.1 ± 2.3
6847.1 4 1793.2 ± 6.6 4184.1 4
150.0 ± 1.2/
731.1 ± 2.6
7217.7 7 133.1 ± 1.4/
677.1 ± 2.7
8507.1 5a 2186.3 ± 8.9 5101.4 9
153.9 ± 0.7/
762.9 ± 1.8
7494.9 8a 143.1 ± 1.7/
709.2 ± 3.2
8949.2 10 2202.5 ± 4.7 5139.2 7
175.5 ± 1.4/
854.4 ± 3.1
8437.8 7 157.3 ± 1.1/
775.8 ± 3.4
9797.6 10 2528.0 ± 12.1 5898.7 5 a
187.5 ± 1.3/
934.3 ± 3.6
9165.1 6 176.1 ± 1.0/
869.9 ± 2.9
10983.0 10 3175.0 ± 9.8 7408.3 10
a Data point(s) dropped from preferred reduced data set for dose–response analysis.
b Data points combined for dose–response analysis (Cavg  t = 7151 ppmmin; deaths = 13/20).
c Data point dropped in alternative analysis (Table 3, italicized results).
d Phase 1 data (Sweeney et al., 2014).
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and
ðC1;50Þ ¼ CR  ðC2;50Þ ð8Þ
Substituting Eq. (8) and Eq. (2) into Eq. (7):
TL50;PW ¼ ðC1;50Þn  t2  DR þ ðC1;50Þn  t2=CRn ð9Þ
Rearranging the terms in Eq. (9):
TL50;PW ¼ ðC1;50Þn  t2  ðDR þ 1=CRnÞ ð10Þ
By definition:
LCt50 ¼ ðC1;50Þ  t1 þ ðC2;50Þ  t2 ð11Þ
Substituting Eq. (8) and Eq. (2) into Eq. (11):
LCt50 ¼ ðC1;50Þ  t2  DR þ ðC1;50Þ  t2=CR ð12Þ
Rearranging terms in Eq. (12):
LCt50 ¼ ðC1;50Þ  t2  ðDR þ 1=CRÞ ð13Þ
Rearranging Eq. (13) to solve for C1,50:
ðC1;50Þ ¼ LCt50=ðt2  ðDR þ 1=CRÞÞ ð14Þ
Substituting Eq. (14) into Eq. (10):
TL50;PW ¼ ½LCt50=ðt2  ðDR þ 1=CRÞÞn  t2  ðDR þ 1=CRnÞ ð15Þ
Rearranging terms in Eq. (15):
TL50;PW ¼ ½LCtn50=tn12   ðDR þ 1=CRnÞ=ðDR þ 1=CRÞn ð16Þ
Substituting Eq. (5) into Eq. (16):
TL50;PW ¼ LCtn50  ½ð1þ DRÞ=ðtall  ð1 f ÞÞn1  ðDR
þ 1=CRnÞ=ðDR þ 1=CRÞn ð17Þ
Rearranging Eq. (17):
TL50;PW ¼ ðLCt50=tallÞn  tall  ½ð1þ DRÞ=ð1 f Þn1  ðDR
þ 1=CRnÞ=ðDR þ 1=CRÞn ð18Þ
Substituting Eq. (6) into Eq. (18):
TL50;PW ¼ TL50;DA  ðDR þ 1=CRnÞ=ðDR þ 1=CRÞn
 ½ð1þ DRÞ=ð1 f Þn1 ð19Þ
Appendix C. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.yrtph.2015.02.
015.
Fig. A-1. Dose–response plots for Profile 4 (4.67-min pulse, 3-min gap, 2.33 min pulse). (a) Each trial entered separately (no combining), all trials included (p = 0.0013,
LCt50 = 5512 ppmmin). (b) Two trials with similar doses combined, all trials included (p = 0.0953, LCt50 = 5514 ppmmin) (c) Two trials with similar doses combined, 2 trials
excluded (p = 0.604, LCt50 = 6329 ppmmin) (selected). (d) Two trials with similar doses combined, 1 trial excluded (p = 0.25, LCt50 = 5733 ppmmin) (alternate).
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Table S-1.  Environmental Parameters 
Profile 1 
(Trial) 
Exposure 
Group  
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of 
water) 
Pulse 1 
Air 
Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air 
Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 2  20130603 Mean 72.9 22.7 47.4 -0.011 2.96 3.54 N/A N/A 
St. dev. 0.1 0.0 0.7 0.002 0.00 0.00 N/A N/A 
(2) 6  20130604 Mean 72.7 22.6 38.0 -0.012 1.55 4.95 N/A N/A 
St. dev. 0.0 0.0 0.3 0.001 0.02 0.00 N/A N/A 
(3) 27 20130618 Mean 74.1 23.4 57.1 -0.006 2.12 4.37 N/A N/A 
St. dev. 0.2 0.1 0.6 0.001 0.00 0.00 N/A N/A 
(4) 37 20130625 Mean 74.3 23.5 62.7 -0.007 2.41 4.08 N/A N/A 
St. dev. 0.2 0.1 0.3 0.001 0.00 0.00 N/A N/A 
(5) 50 20130729 Mean 70.7 21.5 55.8 -0.008 3.42 3.07 N/A N/A 
St. dev. 0.2 0.1 0.4 0.001 0.00 0.00 N/A N/A 
 Minimum Mean 70.7 21.5 38.0 -0.012  
Maximum Mean 74.3 23.5 62.7 -0.006 
 
Profile 2 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air 
Flow 
(SLM) 
Pulse 
1 
HCN 
Flow 
(SLM) 
Pulse 
2 Air 
Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 12 20130610 Mean 71.9 22.2 70.5 -0.010 5.12 1.36 4.89 1.60 
  Std. dev. 0.2 0.1 1.3 0.001 0.00 0.00 0.00 0.00 
(2) 21 20130613 Mean 74.7 23.7 65.7 -0.005 4.17 2.32 4.07 2.42 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(3) 29 20130619 Mean 71.8 22.1 52.0 -0.008 4.64 1.85 4.61 1.88 
  Std. dev. 0.2 0.1 0.9 0.001 0.00 0.00 0.00 0.00 
(4) 34 20130624 Mean 74.3 23.5 61.4 -0.007 4.80 1.69 4.76 1.73 
  Std. dev. 0.2 0.1 0.3 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 71.8 22.1 52.0 -0.010     
 Maximum Mean 74.7 23.7 70.5 -0.005     
 
Profile 3 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 7 20130605 Mean 72.0 22.2 44.1 -0.011 4.98 1.51 2.07 4.41 
  Std. dev. 0.1 0.0 0.7 0.001 0.01 0.01 0.00 0.01 
(2) 15 20130611 Mean 71.8 22.1 67.8 -0.009 5.33 1.16 5.29 1.19 
  Std. dev. 0.2 0.1 2.4 0.001 0.00 0.00 0.00 0.00 
(3) 30 20130619 Mean 72.4 22.4 50.9 -0.008 4.80 1.69 4.75 1.73 
  Std. dev. 0.2 0.1 0.7 0.001 0.00 0.00 0.00 0.00 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(4) 40 20130626 Mean 75.0 23.9 61.1 -0.006 5.17 1.31 5.13 1.36 
  Std. dev. 0.2 0.1 0.4 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 71.8 22.1 44.1 -0.011     
 Maximum Mean 75.0 23.9 67.8 -0.006     
 
Profile 4 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 11 20130606 Mean 72.5 22.5 60.1 -0.009 3.80 2.69 3.45 3.04 
  Std. dev. 0.2 0.1 0.7 0.001 0.01 0.01 0.01 0.00 
(2) 20 20130612 Mean 73.9 23.3 64.9 -0.006 2.89 3.59 2.88 3.61 
  Std. dev. 0.1 0.1 0.4 0.001 0.00 0.00 0.00 0.00 
(3) 26 20130618 Mean 73.6 23.1 59.5 -0.007 3.30 3.19 3.27 3.21 
  Std. dev. 0.2 0.1 1.0 0.001 0.00 0.00 0.00 0.00 
(4) 35 20130624 Mean 74.8 23.8 61.5 -0.005 3.49 3.00 3.45 3.04 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(5) 45 20130701 Mean 73.4 23.0 58.7 -0.007 3.67 2.82 3.59 2.89 
  Std. dev. 0.2 0.1 0.4 0.001 0.00 0.00 0.00 0.00 
(6) 51 20130729 Mean 71.3 21.8 54.4 -0.007 4.13 2.35 4.06 2.43 
  Std. dev. 0.2 0.1 0.4 0.001 0.00 0.00 0.00 0.00 
(7) 55 20130731 Mean 73.4 23.0 59.3 -0.005 4.45 2.03 4.37 2.11 
  Std. dev. 0.2 0.1 0.7 0.001 0.00 0.00 0.00 0.00 
(8) 58 20130827 Mean 72.7 22.6 61.8 -0.006 4.75 1.74 1.11 5.37 
  Std. dev. 0.1 0.1 0.5 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 71.3 21.8 54.4 -0.009     
 Maximum Mean 74.8 23.8 64.9 -0.005     
 
Profile 5 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 8 20130605 Mean 72.1 22.3 44.2 -0.012 4.92 1.57 1.57 4.92 
  Std. dev. 0.1 0.0 0.4 0.001 0.01 0.00 0.00 0.00 
(2) 14 20130610 Mean 72.6 22.6 62.8 -0.010 4.12 2.37 3.78 2.71 
  Std. dev. 0.1 0.1 0.2 0.001 0.00 0.00 0.01 0.00 
(3) 25 20130617 Mean 74.2 23.4 61.8 -0.006 4.48 2.00 4.41 2.08 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(4) 41 20130626 Mean 75.4 24.1 60.0 -0.005 4.65 1.83 4.60 1.88 
  Std. dev. 0.1 0.1 0.5 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 72.1 22.3 44.2 -0.012     
 Maximum Mean 75.4 24.1 62.8 -0.005     
 
Profile 6 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 1 20130603 Mean 72.9 22.7 47.4 -0.010 4.60 1.90 N/A N/A 
  Std. dev. 0.2 0.1 0.8 0.002 0.00 0.00 N/A N/A 
(2) 18 20130612 Mean 72.5 22.5 70.4 -0.009 5.10 1.39 N/A N/A 
  Std. dev. 0.4 0.2 0.8 0.001 0.00 0.00 N/A N/A 
 Minimum Mean 72.5 22.5 47.4 -0.010     
 Maximum Mean 72.9 22.7 70.4 -0.009     
 
Profile 7 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 10 20130606 Mean 72.0 22.2 60.3 -0.010 5.74 0.74 5.72 0.77 
  Std. dev. 0.2 0.1 0.5 0.001 0.01 0.00 0.01 0.01 
(2) 19 20130612 Mean 73.4 23.0 68.9 -0.008 5.90 0.59 5.89 0.60 
  Std. dev. 0.3 0.2 1.1 0.001 0.00 0.00 0.00 0.00 
(3) 31 20130619 Mean 72.9 22.7 48.9 -0.008 5.59 0.90 5.60 0.89 
  Std. dev. 0.2 0.1 0.7 0.001 0.00 0.00 0.00 0.00 
(4) 43 20130627 Mean 74.2 23.5 61.2 -0.007 5.81 0.68 4.46 2.03 
  Std. dev. 0.3 0.2 0.7 0.001 0.00 0.00 0.00 0.00 
(5) 46 20130701 Mean 74.2 23.5 57.0 -0.007 5.96 0.53 5.96 0.53 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(6) 56 20130826 Mean 71.6 22.0 57.7 -0.007 6.04 0.45 5.12 1.36 
  Std. dev. 0.3 0.2 0.4 0.002 0.00 0.00 0.00 0.00 
 Minimum Mean 71.6 22.0 48.9 -0.010     
 Maximum Mean 74.2 23.5 68.9 -0.007     
 
Profile 8 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 5 20130604 Mean 72.5 22.5 39.0 -0.011 5.89 0.60 5.89 0.60 
  Std. dev. 0.3 0.1 0.9 0.001 0.00 0.00 0.00 0.00 
(2) 16 20130611 Mean 72.6 22.5 63.2 -0.007 6.03 0.46 6.03 0.46 
  Std. dev. 0.2 0.1 0.8 0.001 0.00 0.00 0.00 0.00 
(3) 28 20130618 Mean 74.6 23.7 55.0 -0.007 6.09 0.41 6.09 0.40 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(4) 42 20130626 Mean 75.7 24.3 58.8 -0.006 5.79 0.70 5.78 0.71 
  Std. dev. 0.2 0.1 1.1 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 72.5 22.5 39.0 -0.011     
 Maximum Mean 75.7 24.3 63.2 -0.006     
 Profile 9 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 13 20130610 Mean 72.5 22.5 64.0 -0.010 5.48 1.01 5.36 1.12 
  Std. dev. 0.2 0.1 1.5 0.001 0.00 0.00 0.00 0.00 
(2) 22 20130613 Mean 75.4 24.1 62.3 -0.006 5.60 0.89 5.41 0.92 
  Std. dev. 0.2 0.1 0.9 0.001 0.00 0.00 0.89 0.00 
(3) 32 20130620 Mean 71.6 22.0 51.4 -0.009 5.50 0.99 5.49 1.00 
  Std. dev. 0.3 0.2 0.5 0.001 0.00 0.00 0.00 0.00 
(4) 36 20130624 Mean 75.5 24.1 59.6 -0.006 5.66 0.83 5.65 0.84 
  Std. dev. 0.2 0.1 1.1 0.001 0.00 0.00 0.00 0.00 
(5) 44 20130627 Mean 74.9 23.9 60.8 -0.008 5.55 0.94 3.66 2.82 
  Std. dev. 0.1 0.0 1.0 0.001 0.00 0.00 0.00 0.00 
(6) 47 20130701 Mean 74.5 23.6 55.8 -0.007 5.28 1.21 5.24 1.25 
  Std. dev. 0.2 0.1 0.4 0.001 0.00 0.00 0.00 0.00 
(7) 53 20130730 Mean 72.2 22.3 57.7 -0.007 5.54 0.94 5.53 0.96 
  Std. dev. 0.3 0.2 0.5 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 71.6 22.0 51.4 -0.010     
 Maximum Mean 75.5 24.1 64.0 -0.006     
 
Profile 10 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 9 20130605 Mean 72.2 22.3 44.5 -0.012 5.74 0.75 4.02 2.47 
  Std. dev. 0.1 0.1 0.6 0.000 0.00 0.00 0.01 0.01 
(2) 17 20130611 Mean 72.8 22.7 62.5 -0.008 5.37 1.12 5.34 1.15 
  Std. dev. 0.2 0.1 0.3 0.001 0.00 0.00 0.00 0.00 
(3) 24 20130617 Mean 73.9 23.3 62.9 -0.005 5.79 0.70 5.79 0.70 
  Std. dev. 0.2 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(4) 39 20130625 Mean 75.2 24.0 59.8 -0.006 5.48 1.00 5.47 1.02 
  Std. dev. 0.2 0.1 1.0 0.002 0.00 0.01 0.00 0.00 
(5) 48 20130702 Mean 73.6 23.1 58.8 -0.007 5.87 0.62 5.86 0.63 
  Std. dev. 0.3 0.1 0.6 0.001 0.00 0.00 0.00 0.00 
(6) 54 20130731 Mean 72.7 22.6 63.3 -0.006 5.95 0.54 5.94 0.55 
  Std. dev. 0.4 0.2 0.7 0.001 0.00 0.00 0.00 0.00 
(7) 57 20130826 Mean 72.3 22.4 57.5 -0.008 5.58 0.90 3.76 2.73 
  Std. dev. 0.2 0.1 0.9 0.001 0.00 0.00 0.00 0.00 
(8) 59 20130828 Mean 74.2 23.4 62.0 -0.005 5.87 0.62 4.61 1.87 
  Std. dev. 0.2 0.1 0.7 0.002 0.00 0.00 0.00 0.00 
(9) 60 20130829 Mean 73.6 23.1 62.7 -0.005 6.00 0.49 5.01 1.48 
  Std. dev. 0.3 0.2 0.6 0.001 0.00 0.00 0.00 0.00 
 Minimum Mean 72.2 22.3 44.5 -0.012     
 Maximum Mean 75.2 24.0 63.3 -0.005     
 
Profile 11 
(Trial) 
Exposure 
Group 
Date 
YYYYMMDD 
Data 
Type 
Temp. 
(°F) 
Temp. 
(°C) 
Relative 
Humidity 
(percent) 
Static 
Pressure 
(inches 
of water) 
Pulse 1 
Air Flow 
(SLM) 
Pulse 1 
HCN 
Flow 
(SLM) 
Pulse 2 
Air Flow 
(SLM) 
Pulse 2 
HCN 
Flow 
(SLM) 
(1) 3 20130603 Mean 72.5 22.5 48.2 -0.010 2.41 4.08 N/A N/A 
  Std. dev. 0.1 0.0 0.4 0.001 0.00 0.00 N/A N/A 
(2) 4 20130604 Mean 71.9 22.2 41.7 -0.011 3.25 3.24 N/A N/A 
  Std. dev. 0.1 0.1 0.8 0.001 0.00 0.00 N/A N/A 
(3) 23 20130617 Mean 73.1 22.9 64.1 -0.007 2.45 4.03 N/A N/A 
  Std. dev. 0.2 0.1 0.5 0.001 0.00 0.00 N/A N/A 
(4) 33 20130620 Mean 72.5 22.5 52.6 -0.009 3.61 2.88 N/A N/A 
  Std. dev. 0.2 0.1 0.3 0.001 0.00 0.00 N/A N/A 
(5) 38 20130625 Mean 74.8 23.8 61.2 -0.006 4.12 2.36 N/A N/A 
  Std. dev. 0.1 0.1 0.4 0.001 0.00 0.00 N/A N/A 
(6) 49 20130702 Mean 74.0 23.4 58.4 -0.007 3.60 2.89 N/A N/A 
  Std. dev. 0.2 0.1 0.3 0.002 0.00 0.00 N/A N/A 
(7) 52 20130730 Mean 71.2 21.8 58.4 -0.007 4.38 2.10 N/A N/A 
  Std. dev. 0.2 0.1 0.5 0.001 0.00 0.00 N/A N/A 
 Minimum Mean 71.2 21.8 41.7 -0.011     
 Maximum Mean 74.8 23.8 64.1 -0.006     
 
 
Table S-2.  Individual Animal Data 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
1 Trial 1 590.0 0021 4/11/2013 5/31/2013 228.8 53 6/3/2013 248.5 HCN 
1 Trial 1 590.0 0023 4/11/2013 5/31/2013 244.4 53 6/3/2013 272.9 Euthanasia 
1 Trial 1 590.0 0073 4/11/2013 5/31/2013 204.4 53 6/3/2013 232.3 Euthanasia 
1 Trial 1 590.0 0075 4/11/2013 5/31/2013 251.7 53 6/3/2013 279.9 HCN 
1 Trial 1 590.0 0101 4/11/2013 5/31/2013 242.2 53 6/3/2013 269.6 Euthanasia 
1 Trial 1 590.0 0103 4/11/2013 5/31/2013 243.6 53 6/3/2013 267.0 HCN 
1 Trial 1 590.0 0137 4/11/2013 5/31/2013 222.0 53 6/3/2013 253.4 HCN 
1 Trial 1 590.0 0139 4/11/2013 5/31/2013 229.2 53 6/3/2013 258.4 Euthanasia 
1 Trial 1 590.0 0165 4/11/2013 5/31/2013 224.0 53 6/3/2013 252.1 Euthanasia 
1 Trial 1 590.0 0167 4/11/2013 5/31/2013 243.1 53 6/3/2013 271.9 Euthanasia 
1 Trial 2 778.0 0069 4/11/2013 5/31/2013 255.8 54 6/4/2013 287.9 HCN 
1 Trial 2 778.0 0071 4/11/2013 5/31/2013 184.7 54 6/4/2013 212.5 HCN 
1 Trial 2 778.0 0097 4/11/2013 5/31/2013 196.9 54 6/4/2013 232.5 HCN 
1 Trial 2 778.0 0099 4/11/2013 5/31/2013 235.2 54 6/4/2013 277.6 HCN 
1 Trial 2 778.0 0189 4/11/2013 5/31/2013 236.8 54 6/4/2013 272.1 HCN 
1 Trial 2 778.0 0191 4/11/2013 5/31/2013 207.5 54 6/4/2013 244.2 HCN 
1 Trial 2 778.0 0193 4/11/2013 5/31/2013 205.0 54 6/4/2013 241.0 HCN 
1 Trial 2 778.0 0195 4/11/2013 5/31/2013 230.1 54 6/4/2013 268.9 HCN 
1 Trial 2 778.0 0205 4/11/2013 5/31/2013 228.8 54 6/4/2013 261.3 HCN 
1 Trial 2 778.0 0207 4/11/2013 5/31/2013 220.2 54 6/4/2013 256.3 Euthanasia 
1 Trial 3 681.3 0441 4/25/2013 6/14/2013 232.1 54 6/18/2013 266.0 Euthanasia 
1 Trial 3 681.3 0443 4/25/2013 6/14/2013 235.0 54 6/18/2013 269.2 HCN 
1 Trial 3 681.3 0509 4/25/2013 6/14/2013 218.1 54 6/18/2013 257.6 HCN 
1 Trial 3 681.3 0511 4/25/2013 6/14/2013 246.7 54 6/18/2013 282.4 HCN 
1 Trial 3 681.3 0549 4/25/2013 6/14/2013 216.5 54 6/18/2013 251.8 HCN 
1 Trial 3 681.3 0551 4/25/2013 6/14/2013 249.7 54 6/18/2013 300.6 HCN 
1 Trial 3 681.3 0605 4/25/2013 6/14/2013 235.4 54 6/18/2013 277.7 HCN 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
1 Trial 3 681.3 0607 4/25/2013 6/14/2013 232.7 54 6/18/2013 269.5 Euthanasia 
1 Trial 3 681.3 0617 4/25/2013 6/14/2013 236.0 54 6/18/2013 266.0 HCN 
1 Trial 3 681.3 0619 4/25/2013 6/14/2013 226.9 54 6/18/2013 266.4 HCN 
1 Trial 4 642.5 0701 5/2/2013 6/21/2013 237.3 54 6/25/2013 272.0 HCN 
1 Trial 4 642.5 0703 5/2/2013 6/21/2013 241.9 54 6/25/2013 279.0 Euthanasia 
1 Trial 4 642.5 0709 5/2/2013 6/21/2013 250.8 54 6/25/2013 294.7 HCN 
1 Trial 4 642.5 0711 5/2/2013 6/21/2013 229.2 54 6/25/2013 274.7 Euthanasia 
1 Trial 4 642.5 0749 5/2/2013 6/21/2013 237.8 54 6/25/2013 271.9 HCN 
1 Trial 4 642.5 0751 5/2/2013 6/21/2013 239.1 54 6/25/2013 279.9 HCN 
1 Trial 4 642.5 0821 5/2/2013 6/21/2013 229.9 54 6/25/2013 259.3 Euthanasia 
1 Trial 4 642.5 0823 5/2/2013 6/21/2013 245.1 54 6/25/2013 282.9 HCN 
1 Trial 4 642.5 0865 5/2/2013 6/21/2013 224.4 54 6/25/2013 256.6 Euthanasia 
1 Trial 4 642.5 0867 5/2/2013 6/21/2013 246.9 54 6/25/2013 282.3 Euthanasia 
1 Trial 5 489.3 0981 6/6/2013 7/26/2013 229.1 53 7/29/2013 257.5 Euthanasia 
1 Trial 5 489.3 0983 6/6/2013 7/26/2013 220.7 53 7/29/2013 246.8 HCN 
1 Trial 5 489.3 0993 6/6/2013 7/26/2013 224.2 53 7/29/2013 255.6 Euthanasia 
1 Trial 5 489.3 0995 6/6/2013 7/26/2013 220.6 53 7/29/2013 247.6 Euthanasia 
1 Trial 5 489.3 0997 6/6/2013 7/26/2013 222.9 53 7/29/2013 248.8 Euthanasia 
1 Trial 5 489.3 0999 6/6/2013 7/26/2013 224.8 53 7/29/2013 253.9 Euthanasia 
1 Trial 5 489.3 1021 6/6/2013 7/26/2013 226.9 53 7/29/2013 253.4 Euthanasia 
1 Trial 5 489.3 1023 6/6/2013 7/26/2013 227.7 53 7/29/2013 257.3 Euthanasia 
1 Trial 5 489.3 1069 6/6/2013 7/26/2013 223.4 53 7/29/2013 253.2 Euthanasia 
1 Trial 5 489.3 1071 6/6/2013 7/26/2013 239.4 53 7/29/2013 273.3 HCN 
2 Trial 1 234.2/1175.3 0257 4/18/2013 6/7/2013 225.8 53 6/10/2013 251.8 Euthanasia 
2 Trial 1 234.2/1175.3 0259 4/18/2013 6/7/2013 249.3 53 6/10/2013 278.9 Euthanasia 
2 Trial 1 234.2/1175.3 0393 4/18/2013 6/7/2013 230.0 53 6/10/2013 257.8 Euthanasia 
2 Trial 1 234.2/1175.3 0395 4/18/2013 6/7/2013 244.0 53 6/10/2013 272.5 Euthanasia 
2 Trial 1 234.2/1175.3 0401 4/18/2013 6/7/2013 226.8 53 6/10/2013 249.9 Euthanasia 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
2 Trial 1 234.2/1175.3 0403 4/18/2013 6/7/2013 242.4 53 6/10/2013 271.9 Euthanasia 
2 Trial 1 234.2/1175.3 0405 4/18/2013 6/7/2013 245.1 53 6/10/2013 274.5 HCN 
2 Trial 1 234.2/1175.3 0407 4/18/2013 6/7/2013 233.3 53 6/10/2013 263.6 Euthanasia 
2 Trial 1 234.2/1175.3 0437 4/18/2013 6/7/2013 249.4 53 6/10/2013 278.3 Euthanasia 
2 Trial 1 234.2/1175.3 0439 4/18/2013 6/7/2013 253.8 53 6/10/2013 287.4 HCN 
2 Trial 2 357.6/1780.0 0245 4/18/2013 6/7/2013 213.0 56 6/13/2013 267.0 HCN 
2 Trial 2 357.6/1780.0 0247 4/18/2013 6/7/2013 211.6 56 6/13/2013 270.1 HCN 
2 Trial 2 357.6/1780.0 0313 4/18/2013 6/7/2013 209.4 56 6/13/2013 263.7 HCN 
2 Trial 2 357.6/1780.0 0315 4/18/2013 6/7/2013 202.2 56 6/13/2013 252.6 HCN 
2 Trial 2 357.6/1780.0 0349 4/18/2013 6/7/2013 205.7 56 6/13/2013 259.1 HCN 
2 Trial 2 357.6/1780.0 0351 4/18/2013 6/7/2013 202.6 56 6/13/2013 251.2 HCN 
2 Trial 2 357.6/1780.0 0353 4/18/2013 6/7/2013 229.3 56 6/13/2013 277.9 Euthanasia 
2 Trial 2 357.6/1780.0 0355 4/18/2013 6/7/2013 198.7 56 6/13/2013 252.4 HCN 
2 Trial 2 357.6/1780.0 0429 4/18/2013 6/7/2013 198.6 56 6/13/2013 246.2 HCN 
2 Trial 2 357.6/1780.0 0431 4/18/2013 6/7/2013 222.7 56 6/13/2013 276.1 HCN 
2 Trial 3 297.7/1442.6 0541 4/25/2013 6/14/2013 235.5 55 6/19/2013 279.7 HCN 
2 Trial 3 297.7/1442.6 0543 4/25/2013 6/14/2013 218.5 55 6/19/2013 261.5 HCN 
2 Trial 3 297.7/1442.6 0589 4/25/2013 6/14/2013 228.6 55 6/19/2013 273.1 HCN 
2 Trial 3 297.7/1442.6 0591 4/25/2013 6/14/2013 227.5 55 6/19/2013 274.9 HCN 
2 Trial 3 297.7/1442.6 0593 4/25/2013 6/14/2013 227.7 55 6/19/2013 273.5 HCN 
2 Trial 3 297.7/1442.6 0595 4/25/2013 6/14/2013 233.7 55 6/19/2013 275.6 Euthanasia 
2 Trial 3 297.7/1442.6 0621 4/25/2013 6/14/2013 235.2 55 6/19/2013 278.0 HCN 
2 Trial 3 297.7/1442.6 0623 4/25/2013 6/14/2013 224.3 55 6/19/2013 272.3 Euthanasia 
2 Trial 3 297.7/1442.6 0657 4/25/2013 6/14/2013 230.0 55 6/19/2013 278.4 HCN 
2 Trial 3 297.7/1442.6 0659 4/25/2013 6/14/2013 230.5 55 6/19/2013 278.9 Euthanasia 
2 Trial 4 265.5/1299.4 0677 5/2/2013 6/21/2013 227.2 53 6/24/2013 248.1 Euthanasia 
2 Trial 4 265.5/1299.4 0679 5/2/2013 6/21/2013 255.2 53 6/24/2013 288.7 Euthanasia 
2 Trial 4 265.5/1299.4 0681 5/2/2013 6/21/2013 244.7 53 6/24/2013 280.5 HCN 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
2 Trial 4 265.5/1299.4 0683 5/2/2013 6/21/2013 241.3 53 6/24/2013 271.9 Euthanasia 
2 Trial 4 265.5/1299.4 0697 5/2/2013 6/21/2013 240.5 53 6/24/2013 263.8 HCN 
2 Trial 4 265.5/1299.4 0699 5/2/2013 6/21/2013 261.4 53 6/24/2013 297.0 Euthanasia 
2 Trial 4 265.5/1299.4 0801 5/2/2013 6/21/2013 247.5 53 6/24/2013 270.3 Euthanasia 
2 Trial 4 265.5/1299.4 0803 5/2/2013 6/21/2013 236.0 53 6/24/2013 265.7 HCN 
2 Trial 4 265.5/1299.4 0861 5/2/2013 6/21/2013 264.8 53 6/24/2013 297.3 HCN 
2 Trial 4 265.5/1299.4 0863 5/2/2013 6/21/2013 229.4 53 6/24/2013 254.5 HCN 
3 Trial 1 261.7/1157.6 0065 4/11/2013 5/31/2013 209.7 55 6/5/2013 234.2 Euthanasia 
3 Trial 1 261.7/1157.6 0067 4/11/2013 5/31/2013 218.3 55 6/5/2013 238.1 HCN 
3 Trial 1 261.7/1157.6 0089 4/11/2013 5/31/2013 205.3 55 6/5/2013 263.4 Euthanasia 
3 Trial 1 261.7/1157.6 0091 4/11/2013 5/31/2013 202.5 55 6/5/2013 250.2 HCN 
3 Trial 1 261.7/1157.6 0141 4/11/2013 5/31/2013 217.9 55 6/5/2013 263.7 Euthanasia 
3 Trial 1 261.7/1157.6 0143 4/11/2013 5/31/2013 207.2 55 6/5/2013 250.7 HCN 
3 Trial 1 261.7/1157.6 0145 4/11/2013 5/31/2013 208.1 55 6/5/2013 255.5 HCN 
3 Trial 1 261.7/1157.6 0147 4/11/2013 5/31/2013 223.9 55 6/5/2013 267.5 HCN 
3 Trial 1 261.7/1157.6 0213 4/11/2013 5/31/2013 196.4 55 6/5/2013 239.0 Euthanasia 
3 Trial 1 261.7/1157.6 0215 4/11/2013 5/31/2013 222.9 55 6/5/2013 268.7 HCN 
3 Trial 2 183.4/899.9 0289 4/18/2013 6/7/2013 251.8 54 6/11/2013 292.3 Euthanasia 
3 Trial 2 183.4/899.9 0291 4/18/2013 6/7/2013 207.6 54 6/11/2013 243.4 Euthanasia 
3 Trial 2 183.4/899.9 0325 4/18/2013 6/7/2013 213.8 54 6/11/2013 245.0 Euthanasia 
3 Trial 2 183.4/899.9 0327 4/18/2013 6/7/2013 241.0 54 6/11/2013 274.7 Euthanasia 
3 Trial 2 183.4/899.9 0361 4/18/2013 6/7/2013 230.9 54 6/11/2013 261.5 Euthanasia 
3 Trial 2 183.4/899.9 0363 4/18/2013 6/7/2013 215.4 54 6/11/2013 245.6 Euthanasia 
3 Trial 2 183.4/899.9 0369 4/18/2013 6/7/2013 251.8 54 6/11/2013 285.5 HCN 
3 Trial 2 183.4/899.9 0371 4/18/2013 6/7/2013 198.1 54 6/11/2013 220.6 Euthanasia 
3 Trial 2 183.4/899.9 0433 4/18/2013 6/7/2013 224.6 54 6/11/2013 265.0 HCN 
3 Trial 2 183.4/899.9 0435 4/18/2013 6/7/2013 242.9 54 6/11/2013 279.0 HCN 
3 Trial 3 270.8/1331.8 0573 4/25/2013 6/14/2013 247.5 55 6/19/2013 283.8 HCN 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
3 Trial 3 270.8/1331.8 0575 4/25/2013 6/14/2013 211.8 55 6/19/2013 255.3 HCN 
3 Trial 3 270.8/1331.8 0581 4/25/2013 6/14/2013 223.3 55 6/19/2013 269.4 HCN 
3 Trial 3 270.8/1331.8 0583 4/25/2013 6/14/2013 237.0 55 6/19/2013 284.7 HCN 
3 Trial 3 270.8/1331.8 0613 4/25/2013 6/14/2013 242.1 55 6/19/2013 275.9 HCN 
3 Trial 3 270.8/1331.8 0615 4/25/2013 6/14/2013 219.3 55 6/19/2013 247.0 HCN 
3 Trial 3 270.8/1331.8 0629 4/25/2013 6/14/2013 228.4 55 6/19/2013 270.3 HCN 
3 Trial 3 270.8/1331.8 0631 4/25/2013 6/14/2013 224.6 55 6/19/2013 261.7 HCN 
3 Trial 3 270.8/1331.8  0645 4/25/2013 6/14/2013 226.0 55 6/19/2013 269.5 HCN 
3 Trial 3 270.8/1331.8 0647 4/25/2013 6/14/2013 229.2 55 6/19/2013 272.5 HCN 
3 Trial 4 205.1/1014.4 0661 5/2/2013 6/21/2013 224.9 55 6/26/2013 265.9 Euthanasia 
3 Trial 4 205.1/1014.4 0663 5/2/2013 6/21/2013 237.1 55 6/26/2013 280.7 HCN 
3 Trial 4 205.1/1014.4 0717 5/2/2013 6/21/2013 220.4 55 6/26/2013 262.7 Euthanasia 
3 Trial 4 205.1/1014.4 0719 5/2/2013 6/21/2013 242.8 55 6/26/2013 290.3 Euthanasia 
3 Trial 4 205.1/1014.4 0729 5/2/2013 6/21/2013 242.9 55 6/26/2013 288.2 HCN 
3 Trial 4 205.1/1014.4 0731 5/2/2013 6/21/2013 223.4 55 6/26/2013 266.2 HCN 
3 Trial 4 205.1/1014.4 0737 5/2/2013 6/21/2013 244.2 55 6/26/2013 287.9 Euthanasia 
3 Trial 4 205.1/1014.4 0739 5/2/2013 6/21/2013 224.1 55 6/26/2013 264.2 HCN 
3 Trial 4 205.1/1014.4 0809 5/2/2013 6/21/2013 230.3 55 6/26/2013 274.4 HCN 
3 Trial 4 205.1/1014.4 0811 5/2/2013 6/21/2013 240.0 55 6/26/2013 288.3 HCN 
4 Trial 1 444.9/2178.1 0057 4/11/2013 5/31/2013 204.0 56 6/6/2013 251.8 HCN 
4 Trial 1 444.9/2178.1 0059 4/11/2013 5/31/2013 176.5 56 6/6/2013 223.5 HCN 
4 Trial 1 444.9/2178.1 0109 4/11/2013 5/31/2013 175.8 56 6/6/2013 225.2 HCN 
4 Trial 1 444.9/2178.1 0111 4/11/2013 5/31/2013 218.8 56 6/6/2013 274.9 Euthanasia 
4 Trial 1 444.9/2178.1 0125 4/11/2013 5/31/2013 192.1 56 6/6/2013 239.5 Euthanasia 
4 Trial 1 444.9/2178.1 0127 4/11/2013 5/31/2013 194.0 56 6/6/2013 248.7 Euthanasia 
4 Trial 1 444.9/2178.1 0129 4/11/2013 5/31/2013 181.5 56 6/6/2013 244.5 Euthanasia 
4 Trial 1 444.9/2178.1 0131 4/11/2013 5/31/2013 163.2 56 6/6/2013 232.7 Euthanasia 
4 Trial 1 444.9/2178.1 0177 4/11/2013 5/31/2013 189.8 56 6/6/2013 239.8 Euthanasia 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
4 Trial 1 444.9/2178.1 0179 4/11/2013 5/31/2013 208.0 56 6/6/2013 256.0 Euthanasia 
4 Trial 2 566.5/2793.3 0285 4/18/2013 6/7/2013 216.6 55 6/12/2013 257.7 HCN 
4 Trial 2 566.5/2793.3 0287 4/18/2013 6/7/2013 222.4 55 6/12/2013 258.5 HCN 
4 Trial 2 566.5/2793.3 0301 4/18/2013 6/7/2013 224.4 55 6/12/2013 263.1 HCN 
4 Trial 2 566.5/2793.3 0303 4/18/2013 6/7/2013 209.6 55 6/12/2013 238.8 HCN 
4 Trial 2 566.5/2793.3 0321 4/18/2013 6/7/2013 233.9 55 6/12/2013 277.0 HCN 
4 Trial 2 566.5/2793.3 0323 4/18/2013 6/7/2013 194.8 55 6/12/2013 223.1 HCN 
4 Trial 2 566.5/2793.3 0373 4/18/2013 6/7/2013 218.7 55 6/12/2013 267.8 HCN 
4 Trial 2 566.5/2793.3 0375 4/18/2013 6/7/2013 224.6 55 6/12/2013 272.6 HCN 
4 Trial 2 566.5/2793.3 0413 4/18/2013 6/7/2013 209.7 55 6/12/2013 245.8 HCN 
4 Trial 2 566.5/2793.3 0415 4/18/2013 6/7/2013 235.1 55 6/12/2013 285.1 HCN 
4 Trial 3 501.0/2474.9 0501 4/25/2013 6/14/2013 221.6 54 6/18/2013 261.1 Euthanasia 
4 Trial 3 501.0/2474.9 0503 4/25/2013 6/14/2013 243.6 54 6/18/2013 287.3 HCN 
4 Trial 3 501.0/2474.9 0505 4/25/2013 6/14/2013 225.4 54 6/18/2013 262.0 HCN 
4 Trial 3 501.0/2474.9 0507 4/25/2013 6/14/2013 241.0 54 6/18/2013 280.9 Euthanasia 
4 Trial 3 501.0/2474.9 0533 4/25/2013 6/14/2013 222.8 54 6/18/2013 258.2 Euthanasia 
4 Trial 3 501.0/2474.9 0535 4/25/2013 6/14/2013 244.5 54 6/18/2013 282.6 HCN 
4 Trial 3 501.0/2474.9 0557 4/25/2013 6/14/2013 214.0 54 6/18/2013 248.5 HCN 
4 Trial 3 501.0/2474.9 0559 4/25/2013 6/14/2013 254.7 54 6/18/2013 294.4 HCN 
4 Trial 3 501.0/2474.9 0577 4/25/2013 6/14/2013 247.3 54 6/18/2013 284.3 HCN 
4 Trial 3 501.0/2474.9 0579 4/25/2013 6/14/2013 215.7 54 6/18/2013 256.9 HCN 
4 Trial 4 471.8/2331.5 0689 5/2/2013 6/21/2013 242.6 53 6/24/2013 267.1 HCN 
4 Trial 4 471.8/2331.5 0691 5/2/2013 6/21/2013 239.2 53 6/24/2013 259.8 HCN 
4 Trial 4 471.8/2331.5 0733 5/2/2013 6/21/2013 242.1 53 6/24/2013 272.7 HCN 
4 Trial 4 471.8/2331.5 0735 5/2/2013 6/21/2013 257.6 53 6/24/2013 284.9 HCN 
4 Trial 4 471.8/2331.5 0769 5/2/2013 6/21/2013 251.4 53 6/24/2013 280.7 HCN 
4 Trial 4 471.8/2331.5 0771 5/2/2013 6/21/2013 242.5 53 6/24/2013 237.1 HCN 
4 Trial 4 471.8/2331.5 0793 5/2/2013 6/21/2013 246.4 53 6/24/2013 262.7 HCN 
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4 Trial 4 471.8/2331.5 0795 5/2/2013 6/21/2013 238.1 53 6/24/2013 261.7 HCN 
4 Trial 4 471.8/2331.5 0829 5/2/2013 6/21/2013 245.9 53 6/24/2013 274.1 HCN 
4 Trial 4 471.8/2331.5 0831 5/2/2013 6/21/2013 236.9 53 6/24/2013 260.7 HCN 
4 Trial 5 442.0/2177.5 0909 5/9/2013 6/28/2013 219.3 53 7/1/2013 243.1 HCN 
4 Trial 5 442.0/2177.5 0911 5/9/2013 6/28/2013 219.4 53 7/1/2013 241.9 HCN 
4 Trial 5 442.0/2177.5 0949 5/9/2013 6/28/2013 222.4 53 7/1/2013 248.8 HCN 
4 Trial 5 442.0/2177.5 0951 5/9/2013 6/28/2013 244.3 53 7/1/2013 268.9 HCN 
4 Trial 5 442.0/2177.5 0957 5/9/2013 6/28/2013 228.3 53 7/1/2013 251.7 HCN 
4 Trial 5 442.0/2177.5 0959 5/9/2013 6/28/2013 227.7 53 7/1/2013 253.7 HCN 
4 Trial 5 442.0/2177.5 0969 5/9/2013 6/28/2013 261.2 53 7/1/2013 293.7 HCN 
4 Trial 5 442.0/2177.5 0971 5/9/2013 6/28/2013 226.3 53 7/1/2013 254.7 HCN 
4 Trial 5 442.0/2177.5 0973 5/9/2013 6/28/2013 240.4 53 7/1/2013 268.9 HCN 
4 Trial 5 442.0/2177.5 0975 5/9/2013 6/28/2013 206.8 53 7/1/2013 234.7 HCN 
4 Trial 6 376.6/1847.7 1005 6/6/2013 7/26/2013 221.8 53 7/29/2013 253.1 Euthanasia 
4 Trial 6 376.6/1847.7 1007 6/6/2013 7/26/2013 231.0 53 7/29/2013 254.5 Euthanasia 
4 Trial 6 376.6/1847.7 1033 6/6/2013 7/26/2013 232.1 53 7/29/2013 258.8 HCN 
4 Trial 6 376.6/1847.7 1035 6/6/2013 7/26/2013 211.9 53 7/29/2013 235.2 HCN 
4 Trial 6 376.6/1847.7 1037 6/6/2013 7/26/2013 224.6 53 7/29/2013 254.0 Euthanasia 
4 Trial 6 376.6/1847.7 1039 6/6/2013 7/26/2013 237.1 53 7/29/2013 268.3 HCN 
4 Trial 6 376.6/1847.7 1045 6/6/2013 7/26/2013 216.1 53 7/29/2013 247.2 HCN 
4 Trial 6 376.6/1847.7 1047 6/6/2013 7/26/2013 232.7 53 7/29/2013 258.8 HCN 
4 Trial 6 376.6/1847.7 1057 6/6/2013 7/26/2013 227.0 53 7/29/2013 250.4 Euthanasia 
4 Trial 6 376.6/1847.7 1059 6/6/2013 7/26/2013 219.8 53 7/29/2013 242.5 Euthanasia 
4 Trial 7 322.7/1573.6 1025 6/6/2013 7/26/2013 199.8 55 7/31/2013 240.5 Euthanasia 
4 Trial 7 322.7/1573.6 1027 6/6/2013 7/26/2013 213.3 55 7/31/2013 262.7 Euthanasia 
4 Trial 7 322.7/1573.6 1029 6/6/2013 7/26/2013 187.2 55 7/31/2013 222.2 HCN 
4 Trial 7 322.7/1573.6 1031 6/6/2013 7/26/2013 209.3 55 7/31/2013 257.0 HCN 
4 Trial 7 322.7/1573.6 1041 6/6/2013 7/26/2013 210.2 55 7/31/2013 259.9 Euthanasia 
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4 Trial 7 322.7/1573.6 1043 6/6/2013 7/26/2013 208.2 55 7/31/2013 259.8 Euthanasia 
4 Trial 7 322.7/1573.6 1073 6/6/2013 7/26/2013 200.8 55 7/31/2013 251.5 Euthanasia 
4 Trial 7 322.7/1573.6 1075 6/6/2013 7/26/2013 206.4 55 7/31/2013 248.1 Euthanasia 
4 Trial 7 322.7/1573.6 1097 6/6/2013 7/26/2013 229.3 55 7/31/2013 270.8 Euthanasia 
4 Trial 7 322.7/1573.6 1099 6/6/2013 7/26/2013 180.5 55 7/31/2013 211.8 HCN 
4 Trial 8 277.8/1368.6 1125 7/4/2013 8/23/2013 212.1 54 8/27/2013 236.5 HCN 
4 Trial 8 277.8/1368.6 1127 7/4/2013 8/23/2013 249.4 54 8/27/2013 282.8 HCN 
4 Trial 8 277.8/1368.6 1129 7/4/2013 8/23/2013 236.0 54 8/27/2013 278.2 Euthanasia 
4 Trial 8 277.8/1368.6 1131 7/4/2013 8/23/2013 228.8 54 8/27/2013 259.8 HCN 
4 Trial 8 277.8/1368.6 1141 7/4/2013 8/23/2013 217.5 54 8/27/2013 246.0 Euthanasia 
4 Trial 8 277.8/1368.6 1143 7/4/2013 8/23/2013 239.8 54 8/27/2013 275.4 Euthanasia 
4 Trial 8 277.8/1368.6 1149 7/4/2013 8/23/2013 224.7 54 8/27/2013 255.8 HCN 
4 Trial 8 277.8/1368.6 1151 7/4/2013 8/23/2013 240.2 54 8/27/2013 277.4 Euthanasia 
4 Trial 8 277.8/1368.6 1193 7/4/2013 8/23/2013 250.7 54 8/27/2013 287.5 HCN 
4 Trial 8 277.8/1368.6 1195 7/4/2013 8/23/2013 220.7 54 8/27/2013 256.7 HCN 
5 Trial 1 273.0/1280.4 0017 4/11/2013 5/31/2013 197.7 55 6/5/2013 239.0 Euthanasia 
5 Trial 1 273.0/1280.4 0019 4/11/2013 5/31/2013 225.5 55 6/5/2013 275.5 HCN 
5 Trial 1 273.0/1280.4 0045 4/11/2013 5/31/2013 216.2 55 6/5/2013 263.2 Euthanasia 
5 Trial 1 273.0/1280.4 0047 4/11/2013 5/31/2013 214.6 55 6/5/2013 251.7 Euthanasia 
5 Trial 1 273.0/1280.4 0061 4/11/2013 5/31/2013 242.9 55 6/5/2013 290.6 Euthanasia 
5 Trial 1 273.0/1280.4 0063 4/11/2013 5/31/2013 184.2 55 6/5/2013 227.3 HCN 
5 Trial 1 273.0/1280.4 0113 4/11/2013 5/31/2013 172.8 55 6/5/2013 212.7 Euthanasia 
5 Trial 1 273.0/1280.4 0115 4/11/2013 5/31/2013 230.2 55 6/5/2013 271.7 Euthanasia 
5 Trial 1 273.0/1280.4 0149 4/11/2013 5/31/2013 215.2 55 6/5/2013 258.3 HCN 
5 Trial 1 273.0/1280.4 0151 4/11/2013 5/31/2013 203.1 55 6/5/2013 245.6 Euthanasia 
5 Trial 2 397.0/1941.7 0229 4/18/2013 6/7/2013 252.0 53 6/10/2013 280.3 HCN 
5 Trial 2 397.0/1941.7 0231 4/18/2013 6/7/2013 227.4 53 6/10/2013 246.1 HCN 
5 Trial 2 397.0/1941.7 0277 4/18/2013 6/7/2013 239.1 53 6/10/2013 267.0 HCN 
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5 Trial 2 397.0/1941.7 0279 4/18/2013 6/7/2013 231.3 53 6/10/2013 257.1 HCN 
5 Trial 2 397.0/1941.7 0281 4/18/2013 6/7/2013 240.1 53 6/10/2013 267.5 HCN 
5 Trial 2 397.0/1941.7 0283 4/18/2013 6/7/2013 236.4 53 6/10/2013 265.0 HCN 
5 Trial 2 397.0/1941.7 0317 4/18/2013 6/7/2013 243.6 53 6/10/2013 266.7 HCN 
5 Trial 2 397.0/1941.7 0319 4/18/2013 6/7/2013 224.8 53 6/10/2013 250.2 HCN 
5 Trial 2 397.0/1941.7 0385 4/18/2013 6/7/2013 225.1 53 6/10/2013 249.6 HCN 
5 Trial 2 397.0/1941.7 0387 4/18/2013 6/7/2013 249.5 53 6/10/2013 273.3 HCN 
5 Trial 3 316.5/1574.7 0481 4/25/2013 6/14/2013 233.5 53 6/17/2013 260.3 HCN 
5 Trial 3 316.5/1574.7 0483 4/25/2013 6/14/2013 251.9 53 6/17/2013 280.5 Euthanasia 
5 Trial 3 316.5/1574.7 0489 4/25/2013 6/14/2013 244.3 53 6/17/2013 273.0 Euthanasia 
5 Trial 3 316.5/1574.7 0491 4/25/2013 6/14/2013 224.9 53 6/17/2013 256.1 HCN 
5 Trial 3 316.5/1574.7 0497 4/25/2013 6/14/2013 247.3 53 6/17/2013 281.7 HCN 
5 Trial 3 316.5/1574.7 0499 4/25/2013 6/14/2013 239.9 53 6/17/2013 264.2 Euthanasia 
5 Trial 3 316.5/1574.7 0561 4/25/2013 6/14/2013 225.4 53 6/17/2013 257.7 Euthanasia 
5 Trial 3 316.5/1574.7 0563 4/25/2013 6/14/2013 251.0 53 6/17/2013 280.5 HCN 
5 Trial 3 316.5/1574.7 0597 4/25/2013 6/14/2013 250.4 53 6/17/2013 277.2 HCN 
5 Trial 3 316.5/1574.7 0599 4/25/2013 6/14/2013 248.7 53 6/17/2013 280.6 HCN 
5 Trial 4 287.6/1409.1 0673 5/2/2013 6/21/2013 232.2 55 6/26/2013 274.3 HCN 
5 Trial 4 287.6/1409.1 0675 5/2/2013 6/21/2013 237.5 55 6/26/2013 282.3 HCN 
5 Trial 4 287.6/1409.1 0685 5/2/2013 6/21/2013 229.3 55 6/26/2013 273.0 Euthanasia 
5 Trial 4 287.6/1409.1 0687 5/2/2013 6/21/2013 233.5 55 6/26/2013 277.1 Euthanasia 
5 Trial 4 287.6/1409.1 0693 5/2/2013 6/21/2013 231.8 55 6/26/2013 274.8 Euthanasia 
5 Trial 4 287.6/1409.1 0695 5/2/2013 6/21/2013 229.7 55 6/26/2013 272.4 HCN 
5 Trial 4 287.6/1409.1 0789 5/2/2013 6/21/2013 223.8 55 6/26/2013 266.1 HCN 
5 Trial 4 287.6/1409.1 0791 5/2/2013 6/21/2013 244.2 55 6/26/2013 291.5 Euthanasia 
5 Trial 4 287.6/1409.1 0869 5/2/2013 6/21/2013 230.1 55 6/26/2013 274.7 HCN 
5 Trial 4 287.6/1409.1 0871 5/2/2013 6/21/2013 235.5 55 6/26/2013 282.6 Euthanasia 
6 Trial 1 290.0 0005 4/11/2013 5/31/2013 254.3 53 6/3/2013 274.8 HCN 
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6 Trial 1 290.0 0007 4/11/2013 5/31/2013 236.5 53 6/3/2013 264.1 Euthanasia 
6 Trial 1 290.0 0013 4/11/2013 5/31/2013 248.1 53 6/3/2013 274.3 HCN 
6 Trial 1 290.0 0015 4/11/2013 5/31/2013 210.7 53 6/3/2013 233.4 HCN 
6 Trial 1 290.0 0037 4/11/2013 5/31/2013 246.1 53 6/3/2013 267.6 Euthanasia 
6 Trial 1 290.0 0039 4/11/2013 5/31/2013 205.1 53 6/3/2013 227.0 HCN 
6 Trial 1 290.0 0201 4/11/2013 5/31/2013 241.7 53 6/3/2013 270.1 Euthanasia 
6 Trial 1 290.0 0203 4/11/2013 5/31/2013 227.1 53 6/3/2013 251.8 HCN 
6 Trial 1 290.0 0217 4/11/2013 5/31/2013 246.6 53 6/3/2013 273.1 HCN 
6 Trial 1 290.0 0219 4/11/2013 5/31/2013 228.7 53 6/3/2013 252.9 HCN 
6 Trial 2 220.3 0237 4/18/2013 6/7/2013 214.3 55 6/12/2013 255.1 HCN 
6 Trial 2 220.3 0239 4/18/2013 6/7/2013 227.6 55 6/12/2013 266.7 HCN 
6 Trial 2 220.3 0241 4/18/2013 6/7/2013 224.4 55 6/12/2013 272.7 Euthanasia 
6 Trial 2 220.3 0243 4/18/2013 6/7/2013 209.3 55 6/12/2013 250.8 Euthanasia 
6 Trial 2 220.3 0293 4/18/2013 6/7/2013 202.6 55 6/12/2013 247.0 Euthanasia 
6 Trial 2 220.3 0295 4/18/2013 6/7/2013 243.3 55 6/12/2013 281.5 Euthanasia 
6 Trial 2 220.3 0329 4/18/2013 6/7/2013 218.1 55 6/12/2013 261.0 Euthanasia 
6 Trial 2 220.3 0331 4/18/2013 6/7/2013 220.8 55 6/12/2013 260.1 Euthanasia 
6 Trial 2 220.3 0389 4/18/2013 6/7/2013 234.3 55 6/12/2013 275.9 Euthanasia 
6 Trial 2 220.3 0391 4/18/2013 6/7/2013 210.2 55 6/12/2013 249.2 Euthanasia 
7 Trial 1 129.9/604.2 0029 4/11/2013 5/31/2013 192.0 56 6/6/2013 241.4 HCN 
7 Trial 1 129.9/604.2 0031 4/11/2013 5/31/2013 180.7 56 6/6/2013 219.7 HCN 
7 Trial 1 129.9/604.2 0085 4/11/2013 5/31/2013 201.3 56 6/6/2013 260.1 HCN 
7 Trial 1 129.9/604.2 0087 4/11/2013 5/31/2013 194.6 56 6/6/2013 248.7 Euthanasia 
7 Trial 1 129.9/604.2 0093 4/11/2013 5/31/2013 183.7 56 6/6/2013 231.4 HCN 
7 Trial 1 129.9/604.2 0095 4/11/2013 5/31/2013 197.8 56 6/6/2013 249.5 Euthanasia 
7 Trial 1 129.9/604.2 0121 4/11/2013 5/31/2013 186.6 56 6/6/2013 234.8 HCN 
7 Trial 1 129.9/604.2 0123 4/11/2013 5/31/2013 204.3 56 6/6/2013 248.9 Euthanasia 
7 Trial 1 129.9/604.2 0181 4/11/2013 5/31/2013 193.7 56 6/6/2013 253.9 Euthanasia 
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7 Trial 1 129.9/604.2 0183 4/11/2013 5/31/2013 206.1 56 6/6/2013 268.7 HCN 
7 Trial 2 91.6/455.3 0225 4/18/2013 6/7/2013 228.7 55 6/12/2013 273.0 Euthanasia 
7 Trial 2 91.6/455.3 0227 4/18/2013 6/7/2013 203.7 55 6/12/2013 240.6 Euthanasia 
7 Trial 2 91.6/455.3 0261 4/18/2013 6/7/2013 220.5 55 6/12/2013 263.8 Euthanasia 
7 Trial 2 91.6/455.3 0263 4/18/2013 6/7/2013 223.6 55 6/12/2013 271.7 Euthanasia 
7 Trial 2 91.6/455.3 0297 4/18/2013 6/7/2013 215.4 55 6/12/2013 253.2 HCN 
7 Trial 2 91.6/455.3 0299 4/18/2013 6/7/2013 224.5 55 6/12/2013 256.7 Euthanasia 
7 Trial 2 91.6/455.3 0365 4/18/2013 6/7/2013 221.0 55 6/12/2013 271.6 HCN 
7 Trial 2 91.6/455.3 0367 4/18/2013 6/7/2013 224.6 55 6/12/2013 264.3 Euthanasia 
7 Trial 2 91.6/455.3 0377 4/18/2013 6/7/2013 229.5 55 6/12/2013 275.1 HCN 
7 Trial 2 91.6/455.3 0379 4/18/2013 6/7/2013 207.9 55 6/12/2013 247.1 Euthanasia 
7 Trial 3 141.8/693.0 0461 4/25/2013 6/14/2013 237.5 55 6/19/2013 282.9 HCN 
7 Trial 3 141.8/693.0 0463 4/25/2013 6/14/2013 217.0 55 6/19/2013 264.1 HCN 
7 Trial 3 141.8/693.0 0465 4/25/2013 6/14/2013 222.6 55 6/19/2013 269.3 HCN 
7 Trial 3 141.8/693.0 0467 4/25/2013 6/14/2013 237.7 55 6/19/2013 291.1 HCN 
7 Trial 3 141.8/693.0 0493 4/25/2013 6/14/2013 225.2 55 6/19/2013 275.7 Euthanasia 
7 Trial 3 141.8/693.0 0495 4/25/2013 6/14/2013 227.6 55 6/19/2013 269.5 HCN 
7 Trial 3 141.8/693.0 0545 4/25/2013 6/14/2013 223.8 55 6/19/2013 262.9 HCN 
7 Trial 3 141.8/693.0 0547 4/25/2013 6/14/2013 233.7 55 6/19/2013 272.3 HCN 
7 Trial 3 141.8/693.0 0569 4/25/2013 6/14/2013 236.8 55 6/19/2013 287.9 Euthanasia 
7 Trial 3 141.8/693.0 0571 4/25/2013 6/14/2013 223.7 55 6/19/2013 270.8 HCN 
7 Trial 4 104.8/523.9 0665 5/2/2013 6/21/2013 241.2 56 6/27/2013 295.5 Euthanasia 
7 Trial 4 104.8/523.9 0667 5/2/2013 6/21/2013 207.9 56 6/27/2013 260.5 Euthanasia 
7 Trial 4 104.8/523.9 0705 5/2/2013 6/21/2013 235.6 56 6/27/2013 292.5 Euthanasia 
7 Trial 4 104.8/523.9 0707 5/2/2013 6/21/2013 224.8 56 6/27/2013 274.3 HCN 
7 Trial 4 104.8/523.9 0725 5/2/2013 6/21/2013 218.5 56 6/27/2013 267.1 Euthanasia 
7 Trial 4 104.8/523.9 0727 5/2/2013 6/21/2013 237.0 56 6/27/2013 295.0 Euthanasia 
7 Trial 4 104.8/523.9 0777 5/2/2013 6/21/2013 238.9 56 6/27/2013 287.3 Euthanasia 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
7 Trial 4 104.8/523.9 0779 5/2/2013 6/21/2013 218.3 56 6/27/2013 265.4 Euthanasia 
7 Trial 4 104.8/523.9 0797 5/2/2013 6/21/2013 222.4 56 6/27/2013 274.3 Euthanasia 
7 Trial 4 104.8/523.9 0799 5/2/2013 6/21/2013 224.0 56 6/27/2013 270.1 HCN 
7 Trial 5 81.2/406.8 0881 5/9/2013 6/28/2013 208.0 53 7/1/2013 230.9 Euthanasia 
7 Trial 5 81.2/406.8 0883 5/9/2013 6/28/2013 225.4 53 7/1/2013 253.3 HCN 
7 Trial 5 81.2/406.8 0885 5/9/2013 6/28/2013 243.7 53 7/1/2013 271.3 HCN 
7 Trial 5 81.2/406.8 0887 5/9/2013 6/28/2013 242.3 53 7/1/2013 269.0 Euthanasia 
7 Trial 5 81.2/406.8 0917 5/9/2013 6/28/2013 237.1 53 7/1/2013 266.1 HCN 
7 Trial 5 81.2/406.8 0919 5/9/2013 6/28/2013 214.1 53 7/1/2013 235.5 Euthanasia 
7 Trial 5 81.2/406.8 0941 5/9/2013 6/28/2013 213.3 53 7/1/2013 238.4 HCN 
7 Trial 5 81.2/406.8 0943 5/9/2013 6/28/2013 232.4 53 7/1/2013 257.3 Euthanasia 
7 Trial 5 81.2/406.8 0977 5/9/2013 6/28/2013 213.7 53 7/1/2013 239.4 HCN 
7 Trial 5 81.2/406.8 0979 5/9/2013 6/28/2013 245.4 53 7/1/2013 273.4 Euthanasia 
7 Trial 6 69.9/355.7 1101 7/4/2013 8/23/2013 242.5 53 8/26/2013 271.1 Euthanasia 
7 Trial 6 69.9/355.7 1103 7/4/2013 8/23/2013 236.0 53 8/26/2013 264.6 Euthanasia 
7 Trial 6 69.9/355.7 1113 7/4/2013 8/23/2013 245.0 53 8/26/2013 276.8 Euthanasia 
7 Trial 6 69.9/355.7 1115 7/4/2013 8/23/2013 239.7 53 8/26/2013 271.8 HCN 
7 Trial 6 69.9/355.7 1177 7/4/2013 8/23/2013 257.8 53 8/26/2013 286.3 HCN 
7 Trial 6 69.9/355.7 1179 7/4/2013 8/23/2013 236.3 53 8/26/2013 264.1 HCN 
7 Trial 6 69.9/355.7 1185 7/4/2013 8/23/2013 253.0 53 8/26/2013 285.1 Euthanasia 
7 Trial 6 69.9/355.7 1187 7/4/2013 8/23/2013 251.1 53 8/26/2013 278.5 HCN 
7 Trial 6 69.9/355.7 1189 7/4/2013 8/23/2013 266.0 53 8/26/2013 303.6 Euthanasia 
7 Trial 6 69.9/355.7 1191 7/4/2013 8/23/2013 258.5 53 8/26/2013 288.4 Euthanasia 
8 Trial 1 94.0/472.0 0033 4/11/2013 5/31/2013 216.5 54 6/4/2013 247.0 HCN 
8 Trial 1 94.0/472.0 0035 4/11/2013 5/31/2013 230.4 54 6/4/2013 257.2 HCN 
8 Trial 1 94.0/472.0 0117 4/11/2013 5/31/2013 228.2 54 6/4/2013 259.2 HCN 
8 Trial 1 94.0/472.0 0119 4/11/2013 5/31/2013 204.5 54 6/4/2013 240.2 Euthanasia 
8 Trial 1 94.0/472.0 0133 4/11/2013 5/31/2013 216.9 54 6/4/2013 241.2 Euthanasia 
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8 Trial 1 94.0/472.0 0135 4/11/2013 5/31/2013 225.0 54 6/4/2013 265.8 Euthanasia 
8 Trial 1 94.0/472.0 0161 4/11/2013 5/31/2013 214.4 54 6/4/2013 246.4 HCN 
8 Trial 1 94.0/472.0 0163 4/11/2013 5/31/2013 220.9 54 6/4/2013 256.8 HCN 
8 Trial 1 94.0/472.0 0197 4/11/2013 5/31/2013 233.3 54 6/4/2013 269.0 Euthanasia 
8 Trial 1 94.0/472.0 0199 4/11/2013 5/31/2013 217.0 54 6/4/2013 249.1 HCN 
8 Trial 2 71.2/359.7 0249 4/18/2013 6/7/2013 219.2 54 6/11/2013 246.5 HCN 
8 Trial 2 71.2/359.7 0251 4/18/2013 6/7/2013 233.0 54 6/11/2013 269.6 Euthanasia 
8 Trial 2 71.2/359.7 0305 4/18/2013 6/7/2013 220.4 54 6/11/2013 257.0 HCN 
8 Trial 2 71.2/359.7 0307 4/18/2013 6/7/2013 225.8 54 6/11/2013 259.0 HCN 
8 Trial 2 71.2/359.7 0337 4/18/2013 6/7/2013 233.4 54 6/11/2013 269.1 Euthanasia 
8 Trial 2 71.2/359.7 0339 4/18/2013 6/7/2013 233.9 54 6/11/2013 275.8 HCN 
8 Trial 2 71.2/359.7 0345 4/18/2013 6/7/2013 232.7 54 6/11/2013 266.5 Euthanasia 
8 Trial 2 71.2/359.7 0347 4/18/2013 6/7/2013 216.8 54 6/11/2013 249.2 Euthanasia 
8 Trial 2 71.2/359.7 0421 4/18/2013 6/7/2013 213.2 54 6/11/2013 237.1 Euthanasia 
8 Trial 2 71.2/359.7 0423 4/18/2013 6/7/2013 245.3 54 6/11/2013 288.7 Euthanasia 
8 Trial 3 62.1/314.5 0469 4/25/2013 6/14/2013 246.7 54 6/18/2013 276.6 Euthanasia 
8 Trial 3 62.1/314.5 0471 4/25/2013 6/14/2013 219.4 54 6/18/2013 255.8 Euthanasia 
8 Trial 3 62.1/314.5 0473 4/25/2013 6/14/2013 226.9 54 6/18/2013 262.5 Euthanasia 
8 Trial 3 62.1/314.5 0475 4/25/2013 6/14/2013 240.1 54 6/18/2013 275.0 Euthanasia 
8 Trial 3 62.1/314.5 0553 4/25/2013 6/14/2013 233.5 54 6/18/2013 270.6 Euthanasia 
8 Trial 3 62.1/314.5 0555 4/25/2013 6/14/2013 230.2 54 6/18/2013 269.6 Euthanasia 
8 Trial 3 62.1/314.5 0565 4/25/2013 6/14/2013 229.8 54 6/18/2013 270.1 Euthanasia 
8 Trial 3 62.1/314.5 0567 4/25/2013 6/14/2013 233.0 54 6/18/2013 265.2 Euthanasia 
8 Trial 3 62.1/314.5 0653 4/25/2013 6/14/2013 228.2 54 6/18/2013 264.6 Euthanasia 
8 Trial 3 62.1/314.5 0655 4/25/2013 6/14/2013 239.6 54 6/18/2013 280.0 Euthanasia 
8 Trial 4 108.5/543.0 0761 5/2/2013 6/21/2013 235.7 55 6/26/2013 285.1 HCN 
8 Trial 4 108.5/543.0 0763 5/2/2013 6/21/2013 231.1 55 6/26/2013 278.0 HCN 
8 Trial 4 108.5/543.0 0805 5/2/2013 6/21/2013 230.1 55 6/26/2013 274.8 HCN 
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8 Trial 4 108.5/543.0 0807 5/2/2013 6/21/2013 230.7 55 6/26/2013 281.4 HCN 
8 Trial 4 108.5/543.0 0833 5/2/2013 6/21/2013 236.5 55 6/26/2013 275.0 HCN 
8 Trial 4 108.5/543.0 0835 5/2/2013 6/21/2013 225.8 55 6/26/2013 273.4 HCN 
8 Trial 4 108.5/543.0 0873 5/2/2013 6/21/2013 228.9 55 6/26/2013 266.5 Euthanasia 
8 Trial 4 108.5/543.0 0875 5/2/2013 6/21/2013 236.7 55 6/26/2013 276.3 HCN 
8 Trial 4 108.5/543.0 0877 5/2/2013 6/21/2013 238.1 55 6/26/2013 297.7 HCN 
8 Trial 4 108.5/543.0 0879 5/2/2013 6/21/2013 231.4 55 6/26/2013 269.6 HCN 
9 Trial 1 175.5/854.4 0309 4/18/2013 6/7/2013 235.3 53 6/10/2013 267.2 Cause 
Undetermineda 
9 Trial 1 175.5/854.4 0311 4/18/2013 6/7/2013 245.6 53 6/10/2013 270.0 Euthanasia 
9 Trial 1 175.5/854.4 0357 4/18/2013 6/7/2013 253.0 53 6/10/2013 277.8 HCN 
9 Trial 1 175.5/854.4 0359 4/18/2013 6/7/2013 221.7 53 6/10/2013 244.5 HCN 
9 Trial 1 175.5/854.4 0381 4/18/2013 6/7/2013 231.2 53 6/10/2013 260.6 HCN 
9 Trial 1 175.5/854.4 0383 4/18/2013 6/7/2013 238.0 53 6/10/2013 262.5 HCN 
9 Trial 1 175.5/854.4 0409 4/18/2013 6/7/2013 248.3 53 6/10/2013 284.9 Euthanasia 
9 Trial 1 175.5/854.4 0411 4/18/2013 6/7/2013 224.2 53 6/10/2013 251.5 HCN 
9 Trial 1 175.5/854.4 0417 4/18/2013 6/7/2013 248.7 53 6/10/2013 278.3 HCN 
9 Trial 1 175.5/854.4 0419 4/18/2013 6/7/2013 229.2 53 6/10/2013 255.1 HCN 
9 Trial 2 135.0/685.2 0221 4/18/2013 6/7/2013 206.2 56 6/13/2013 261.4 Euthanasia 
9 Trial 2 135.0/685.2 0223 4/18/2013 6/7/2013 202.8 56 6/13/2013 257.2 Euthanasia 
9 Trial 2 135.0/685.2 0233 4/18/2013 6/7/2013 216.5 56 6/13/2013 270.4 Euthanasia 
9 Trial 2 135.0/685.2 0235 4/18/2013 6/7/2013 207.8 56 6/13/2013 254.8 Euthanasia 
9 Trial 2 135.0/685.2 0265 4/18/2013 6/7/2013 200.2 56 6/13/2013 254.0 Euthanasia 
9 Trial 2 135.0/685.2 0267 4/18/2013 6/7/2013 204.8 56 6/13/2013 269.1 HCN 
9 Trial 2 135.0/685.2 0333 4/18/2013 6/7/2013 219.3 56 6/13/2013 267.1 Euthanasia 
9 Trial 2 135.0/685.2 0335 4/18/2013 6/7/2013 206.1 56 6/13/2013 255.1 HCN 
9 Trial 2 135.0/685.2 0425 4/18/2013 6/7/2013 214.5 56 6/13/2013 259.4 Euthanasia 
9 Trial 2 135.0/685.2 0427 4/18/2013 6/7/2013 203.8 56 6/13/2013 249.9 Euthanasia 
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9 Trial 3 153.9/762.9 0445 4/25/2013 6/14/2013 211.3 56 6/20/2013 259.9 HCN 
9 Trial 3 153.9/762.9 0447 4/25/2013 6/14/2013 229.2 56 6/20/2013 283.6 HCN 
9 Trial 3 153.9/762.9 0457 4/25/2013 6/14/2013 211.1 56 6/20/2013 257.4 HCN 
9 Trial 3 153.9/762.9 0459 4/25/2013 6/14/2013 213.1 56 6/20/2013 257.0 HCN 
9 Trial 3 153.9/762.9 0517 4/25/2013 6/14/2013 225.5 56 6/20/2013 287.1 HCN 
9 Trial 3 153.9/762.9 0519 4/25/2013 6/14/2013 225.4 56 6/20/2013 274.4 HCN 
9 Trial 3 153.9/762.9 0521 4/25/2013 6/14/2013 226.9 56 6/20/2013 286.5 Euthanasia 
9 Trial 3 153.9/762.9 0523 4/25/2013 6/14/2013 216.1 56 6/20/2013 268.8 HCN 
9 Trial 3 153.9/762.9 0601 4/25/2013 6/14/2013 211.8 56 6/20/2013 255.0 Euthanasia 
9 Trial 3 153.9/762.9 0603 4/25/2013 6/14/2013 223.2 56 6/20/2013 284.7 HCN 
9 Trial 4 128.0/641.8 0721 5/2/2013 6/21/2013 238.5 53 6/24/2013 266.4 Euthanasia 
9 Trial 4 128.0/641.8 0723 5/2/2013 6/21/2013 242.6 53 6/24/2013 267.5 HCN 
9 Trial 4 128.0/641.8 0757 5/2/2013 6/21/2013 245.9 53 6/24/2013 276.3 Euthanasia 
9 Trial 4 128.0/641.8 0759 5/2/2013 6/21/2013 250.9 53 6/24/2013 280.7 Euthanasia 
9 Trial 4 128.0/641.8 0765 5/2/2013 6/21/2013 237.5 53 6/24/2013 263.2 Euthanasia 
9 Trial 4 128.0/641.8 0767 5/2/2013 6/21/2013 246.8 53 6/24/2013 277.3 HCN 
9 Trial 4 128.0/641.8 0825 5/2/2013 6/21/2013 254.5 53 6/24/2013 280.2 Euthanasia 
9 Trial 4 128.0/641.8 0827 5/2/2013 6/21/2013 235.0 53 6/24/2013 267.1 Euthanasia 
9 Trial 4 128.0/641.8 0845 5/2/2013 6/21/2013 237.6 53 6/24/2013 264.0 Euthanasia 
9 Trial 4 128.0/641.8 0847 5/2/2013 6/21/2013 244.9 53 6/24/2013 270.7 Euthanasia 
9 Trial 5 144.2/722.4 0741 5/2/2013 6/21/2013 233.1 56 6/27/2013 294.5 Euthanasia 
9 Trial 5 144.2/722.4 0743 5/2/2013 6/21/2013 226.3 56 6/27/2013 275.5 HCN 
9 Trial 5 144.2/722.4 0745 5/2/2013 6/21/2013 233.9 56 6/27/2013 274.2 Euthanasia 
9 Trial 5 144.2/722.4 0747 5/2/2013 6/21/2013 223.0 56 6/27/2013 274.8 Euthanasia 
9 Trial 5 144.2/722.4 0773 5/2/2013 6/21/2013 232.5 56 6/27/2013 280.1 Euthanasia 
9 Trial 5 144.2/722.4 0775 5/2/2013 6/21/2013 222.0 56 6/27/2013 273.7 HCN 
9 Trial 5 144.2/722.4 0781 5/2/2013 6/21/2013 230.9 56 6/27/2013 285.0 Euthanasia 
9 Trial 5 144.2/722.4 0783 5/2/2013 6/21/2013 217.7 56 6/27/2013 261.7 Euthanasia 
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9 Trial 5 144.2/722.4 0837 5/2/2013 6/21/2013 222.7 56 6/27/2013 270.9 Euthanasia 
9 Trial 5 144.2/722.4 0839 5/2/2013 6/21/2013 218.2 56 6/27/2013 256.3 Euthanasia 
9 Trial 6 187.5/934.3 0897 5/9/2013 6/28/2013 211.5 53 7/1/2013 245.8 HCN 
9 Trial 6 187.5/934.3 0899 5/9/2013 6/28/2013 230.2 53 7/1/2013 256.6 Euthanasia 
9 Trial 6 187.5/934.3 0901 5/9/2013 6/28/2013 242.8 53 7/1/2013 268.1 HCN 
9 Trial 6 187.5/934.3 0903 5/9/2013 6/28/2013 207.8 53 7/1/2013 233.7 Euthanasia 
9 Trial 6 187.5/934.3 0905 5/9/2013 6/28/2013 214.1 53 7/1/2013 243.3 HCN 
9 Trial 6 187.5/934.3 0907 5/9/2013 6/28/2013 242.6 53 7/1/2013 274.1 HCN 
9 Trial 6 187.5/934.3 0937 5/9/2013 6/28/2013 248.6 53 7/1/2013 274.9 HCN 
9 Trial 6 187.5/934.3 0939 5/9/2013 6/28/2013 230.4 53 7/1/2013 259.3 Euthanasia 
9 Trial 6 187.5/934.3 0945 5/9/2013 6/28/2013 229.3 53 7/1/2013 257.3 HCN 
9 Trial 6 187.5/934.3 0947 5/9/2013 6/28/2013 203.0 53 7/1/2013 227.9 Euthanasia 
9 Trial 7 150.0/731.1 0985 6/6/2013 7/26/2013 212.6 54 7/30/2013 255.1 HCN 
9 Trial 7 150.0/731.1 0987 6/6/2013 7/26/2013 225.2 54 7/30/2013 248.3 HCN 
9 Trial 7 150.0/731.1 0989 6/6/2013 7/26/2013 206.5 54 7/30/2013 234.3 HCN 
9 Trial 7 150.0/731.1 0991 6/6/2013 7/26/2013 216.0 54 7/30/2013 252.1 Euthanasia 
9 Trial 7 150.0/731.1 1001 6/6/2013 7/26/2013 213.8 54 7/30/2013 253.9 HCN 
9 Trial 7 150.0/731.1 1003 6/6/2013 7/26/2013 227.0 54 7/30/2013 263.6 Euthanasia 
9 Trial 7 150.0/731.1 1009 6/6/2013 7/26/2013 210.0 54 7/30/2013 247.1 HCN 
9 Trial 7 150.0/731.1 1011 6/6/2013 7/26/2013 217.0 54 7/30/2013 252.9 Euthanasia 
9 Trial 7 150.0/731.1 1061 6/6/2013 7/26/2013 203.1 54 7/30/2013 237.3 HCN 
9 Trial 7 150.0/731.1 1063 6/6/2013 7/26/2013 231.0 54 7/30/2013 269.2 HCN 
10 Trial 1 133.1/677.1 0001 4/11/2013 5/31/2013 178.3 55 6/5/2013 216.1 Euthanasia 
10 Trial 1 133.1/677.1 0003 4/11/2013 5/31/2013 250.3 55 6/5/2013 297.8 Euthanasia 
10 Trial 1 133.1/677.1 0041 4/11/2013 5/31/2013 211.6 55 6/5/2013 256.0 Euthanasia 
10 Trial 1 133.1/677.1 0043 4/11/2013 5/31/2013 215.1 55 6/5/2013 254.8 HCN 
10 Trial 1 133.1/677.1 0153 4/11/2013 5/31/2013 225.0 55 6/5/2013 270.3 HCN 
10 Trial 1 133.1/677.1 0155 4/11/2013 5/31/2013 177.7 55 6/5/2013 211.9 Euthanasia 
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10 Trial 1 133.1/677.1 0157 4/11/2013 5/31/2013 199.1 55 6/5/2013 239.3 Euthanasia 
10 Trial 1 133.1/677.1 0159 4/11/2013 5/31/2013 222.2 55 6/5/2013 260.8 HCN 
10 Trial 1 133.1/677.1 0169 4/11/2013 5/31/2013 219.6 55 6/5/2013 263.2 HCN 
10 Trial 1 133.1/677.1 0171 4/11/2013 5/31/2013 196.9 55 6/5/2013 242.3 HCN 
10 Trial 2 176.1/869.9 0253 4/18/2013 6/7/2013 224.4 54 6/11/2013 267.4 HCN 
10 Trial 2 176.1/869.9 0255 4/18/2013 6/7/2013 235.6 54 6/11/2013 272.8 HCN 
10 Trial 2 176.1/869.9 0269 4/18/2013 6/7/2013 217.5 54 6/11/2013 252.7 HCN 
10 Trial 2 176.1/869.9 0271 4/18/2013 6/7/2013 232.7 54 6/11/2013 269.9 HCN 
10 Trial 2 176.1/869.9 0273 4/18/2013 6/7/2013 213.0 54 6/11/2013 248.7 HCN 
10 Trial 2 176.1/869.9 0275 4/18/2013 6/7/2013 243.8 54 6/11/2013 281.1 HCN 
10 Trial 2 176.1/869.9 0341 4/18/2013 6/7/2013 211.6 54 6/11/2013 245.3 HCN 
10 Trial 2 176.1/869.9 0343 4/18/2013 6/7/2013 236.1 54 6/11/2013 270.5 HCN 
10 Trial 2 176.1/869.9 0397 4/18/2013 6/7/2013 234.5 54 6/11/2013 263.9 HCN 
10 Trial 2 176.1/869.9 0399 4/18/2013 6/7/2013 211.5 54 6/11/2013 235.7 HCN 
10 Trial 3 108.0/544.1 0453 4/25/2013 6/14/2013 241.1 53 6/17/2013 269.9 Euthanasia 
10 Trial 3 108.0/544.1 0455 4/25/2013 6/14/2013 242.0 53 6/17/2013 268.1 Euthanasia 
10 Trial 3 108.0/544.1 0513 4/25/2013 6/14/2013 236.6 53 6/17/2013 263.3 HCN 
10 Trial 3 108.0/544.1 0515 4/25/2013 6/14/2013 256.0 53 6/17/2013 286.6 Euthanasia 
10 Trial 3 108.0/544.1 0529 4/25/2013 6/14/2013 259.8 53 6/17/2013 289.1 Euthanasia 
10 Trial 3 108.0/544.1 0531 4/25/2013 6/14/2013 225.7 53 6/17/2013 250.3 Euthanasia 
10 Trial 3 108.0/544.1 0537 4/25/2013 6/14/2013 277.2 53 6/17/2013 320.0 Euthanasia 
10 Trial 3 108.0/544.1 0539 4/25/2013 6/14/2013 230.6 53 6/17/2013 260.2 HCN 
10 Trial 3 108.0/544.1 0585 4/25/2013 6/14/2013 239.4 53 6/17/2013 268.4 HCN 
10 Trial 3 108.0/544.1 0587 4/25/2013 6/14/2013 231.2 53 6/17/2013 254.3 HCN 
10 Trial 4 157.3/775.8 0669 5/2/2013 6/21/2013 240.9 54 6/25/2013 275.6 HCN 
10 Trial 4 157.3/775.8 0671 5/2/2013 6/21/2013 236.0 54 6/25/2013 273.3 HCN 
10 Trial 4 157.3/775.8 0813 5/2/2013 6/21/2013 233.7 54 6/25/2013 265.4 HCN 
10 Trial 4 157.3/775.8 0815 5/2/2013 6/21/2013 237.0 54 6/25/2013 277.5 HCN 
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10 Trial 4 157.3/775.8 0817 5/2/2013 6/21/2013 247.7 54 6/25/2013 282.9 HCN 
10 Trial 4 157.3/775.8 0819 5/2/2013 6/21/2013 225.5 54 6/25/2013 260.1 HCN 
10 Trial 4 157.3/775.8 0841 5/2/2013 6/21/2013 242.2 54 6/25/2013 276.0 HCN 
10 Trial 4 157.3/775.8 0843 5/2/2013 6/21/2013 233.6 54 6/25/2013 261.9 HCN 
10 Trial 4 157.3/775.8 0849 5/2/2013 6/21/2013 241.4 54 6/25/2013 271.6 HCN 
(postexposure) 
10 Trial 4 157.3/775.8 0851 5/2/2013 6/21/2013 238.0 54 6/25/2013 276.6 HCN 
10 Trial 5 95.8/479.4 0893 5/9/2013 6/28/2013 211.4 54 7/2/2013 243.4 Euthanasia 
10 Trial 5 95.8/479.4 0895 5/9/2013 6/28/2013 193.0 54 7/2/2013 224.0 HCN 
10 Trial 5 95.8/479.4 0929 5/9/2013 6/28/2013 201.2 54 7/2/2013 239.4 HCN 
10 Trial 5 95.8/479.4 0931 5/9/2013 6/28/2013 219.8 54 7/2/2013 256.2 Euthanasia 
10 Trial 5 95.8/479.4 0933 5/9/2013 6/28/2013 201.6 54 7/2/2013 236.5 Euthanasia 
10 Trial 5 95.8/479.4 0935 5/9/2013 6/28/2013 213.6 54 7/2/2013 249.3 HCN 
10 Trial 5 95.8/479.4 0953 5/9/2013 6/28/2013 219.9 54 7/2/2013 256.3 HCN 
10 Trial 5 95.8/479.4 0955 5/9/2013 6/28/2013 203.8 54 7/2/2013 229.8 HCN 
10 Trial 5 95.8/479.4 0961 5/9/2013 6/28/2013 192.0 54 7/2/2013 219.3 HCN 
10 Trial 5 95.8/479.4 0963 5/9/2013 6/28/2013 238.3 54 7/2/2013 271.5 Euthanasia 
10 Trial 6 84.3/416.3 1065 6/6/2013 7/26/2013 191.5 55 7/31/2013 226.3 HCN 
10 Trial 6 84.3/416.3 1067 6/6/2013 7/26/2013 209.2 55 7/31/2013 249.3 Euthanasia 
10 Trial 6 84.3/416.3 1077 6/6/2013 7/26/2013 204.9 55 7/31/2013 241.9 Euthanasia 
10 Trial 6 84.3/416.3 1079 6/6/2013 7/26/2013 204.4 55 7/31/2013 250.4 Euthanasia 
10 Trial 6 84.3/416.3 1081 6/6/2013 7/26/2013 200.4 55 7/31/2013 245.5 Euthanasia 
10 Trial 6 84.3/416.3 1083 6/6/2013 7/26/2013 221.6 55 7/31/2013 265.6 HCN 
10 Trial 6 84.3/416.3 1085 6/6/2013 7/26/2013 212.0 55 7/31/2013 257.5 Euthanasia 
10 Trial 6 84.3/416.3 1087 6/6/2013 7/26/2013 206.4 55 7/31/2013 250.8 Euthanasia 
10 Trial 6 84.3/416.3 1089 6/6/2013 7/26/2013 217.1 55 7/31/2013 260.4 HCN 
10 Trial 6 84.3/416.3 1091 6/6/2013 7/26/2013 195.6 55 7/31/2013 235.7 Euthanasia 
10 Trial 7 143.1/709.2 1145 7/4/2013 8/23/2013 262.0 53 8/26/2013 285.8 HCN 
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10 Trial 7 143.1/709.2 1147 7/4/2013 8/23/2013 253.4 53 8/26/2013 278.2 HCN 
10 Trial 7 143.1/709.2 1169 7/4/2013 8/23/2013 267.5 53 8/26/2013 303.1 HCN 
10 Trial 7 143.1/709.2 1171 7/4/2013 8/23/2013 223.7 53 8/26/2013 249.6 HCN 
10 Trial 7 143.1/709.2 1173 7/4/2013 8/23/2013 231.7 53 8/26/2013 258.6 HCN 
10 Trial 7 143.1/709.2 1175 7/4/2013 8/23/2013 247.0 53 8/26/2013 272.3 HCN 
10 Trial 7 143.1/709.2 1181 7/4/2013 8/23/2013 244.5 53 8/26/2013 272.8 HCN 
10 Trial 7 143.1/709.2 1183 7/4/2013 8/23/2013 227.9 53 8/26/2013 257.3 HCN 
10 Trial 7 143.1/709.2 1197 7/4/2013 8/23/2013 264.5 53 8/26/2013 291.4 HCN 
10 Trial 7 143.1/709.2 1199 7/4/2013 8/23/2013 229.9 53 8/26/2013 250.7 HCN 
10 Trial 8 96.6/475.5 1105 7/4/2013 8/23/2013 232.8 55 8/28/2013 269.9 Euthanasia 
10 Trial 8 96.6/475.5 1107 7/4/2013 8/23/2013 223.1 55 8/28/2013 259.4 Euthanasia 
10 Trial 8 96.6/475.5 1133 7/4/2013 8/23/2013 202.9 55 8/28/2013 241.3 HCN 
10 Trial 8 96.6/475.5 1135 7/4/2013 8/23/2013 247.5 55 8/28/2013 288.5 HCN 
10 Trial 8 96.6/475.5 1157 7/4/2013 8/23/2013 215.9 55 8/28/2013 259.7 HCN 
10 Trial 8 96.6/475.5 1159 7/4/2013 8/23/2013 231.8 55 8/28/2013 273.6 Euthanasia 
10 Trial 8 96.6/475.5 1161 7/4/2013 8/23/2013 223.1 55 8/28/2013 278.3 HCN 
10 Trial 8 96.6/475.5 1163 7/4/2013 8/23/2013 233.7 55 8/28/2013 268.6 HCN 
10 Trial 8 96.6/475.5 1165 7/4/2013 8/23/2013 230.2 55 8/28/2013 288.3 Euthanasia 
10 Trial 8 96.6/475.5 1167 7/4/2013 8/23/2013 223.5 55 8/28/2013 270.3 Euthanasia 
10 Trial 9 76.8/377.5 1109 7/4/2013 8/23/2013 222.2 56 8/29/2013 266.3 Euthanasia 
10 Trial 9 76.8/377.5 1111 7/4/2013 8/23/2013 215.1 56 8/29/2013 264.9 Euthanasia 
10 Trial 9 76.8/377.5 1117 7/4/2013 8/23/2013 221.7 56 8/29/2013 263.2 Euthanasia 
10 Trial 9 76.8/377.5 1119 7/4/2013 8/23/2013 225.0 56 8/29/2013 277.2 Euthanasia 
10 Trial 9 76.8/377.5 1121 7/4/2013 8/23/2013 209.8 56 8/29/2013 259.1 Euthanasia 
10 Trial 9 76.8/377.5 1123 7/4/2013 8/23/2013 236.3 56 8/29/2013 286.5 Euthanasia 
10 Trial 9 76.8/377.5 1137 7/4/2013 8/23/2013 212.6 56 8/29/2013 261.3 Euthanasia 
10 Trial 9 76.8/377.5 1139 7/4/2013 8/23/2013 231.5 56 8/29/2013 282.7 Euthanasia 
10 Trial 9 76.8/377.5 1153 7/4/2013 8/23/2013 193.7 56 8/29/2013 239.8 HCN 
Profile 
(1-11) 
Trial 
Number 
Concentration 
(ppm) 
Animal 
# 
Date of 
Birth 
Date 
Weighed 
Random-
ization 
Weight (g) 
Age at 
Exposure 
(days) 
Date of 
Exposure 
Weight at 
Exposure 
(g) 
Mode of Death 
10 Trial 9 76.8/377.5 1155 7/4/2013 8/23/2013 235.7 56 8/29/2013 274.1 Euthanasia 
11 Trial 1 1239.0 0009 4/11/2013 5/31/2013 225.1 53 6/3/2013 243.7 Euthanasia 
11 Trial 1 1239.0 0011 4/11/2013 5/31/2013 247.1 53 6/3/2013 266.7 Euthanasia 
11 Trial 1 1239.0 0049 4/11/2013 5/31/2013 218.3 53 6/3/2013 233.7 Euthanasia 
11 Trial 1 1239.0 0051 4/11/2013 5/31/2013 263.4 53 6/3/2013 296.3 Euthanasia 
11 Trial 1 1239.0 0077 4/11/2013 5/31/2013 239.4 53 6/3/2013 266.5 Euthanasia 
11 Trial 1 1239.0 0079 4/11/2013 5/31/2013 216.0 53 6/3/2013 241.4 Euthanasia 
11 Trial 1 1239.0 0105 4/11/2013 5/31/2013 243.5 53 6/3/2013 264.7 Euthanasia 
11 Trial 1 1239.0 0107 4/11/2013 5/31/2013 207.0 53 6/3/2013 232.1 Euthanasia 
11 Trial 1 1239.0 0173 4/11/2013 5/31/2013 252.0 53 6/3/2013 279.8 Euthanasia 
11 Trial 1 1239.0 0175 4/11/2013 5/31/2013 209.7 53 6/3/2013 238.8 Euthanasia 
11 Trial 2 2528.0 0025 4/11/2013 5/31/2013 222.9 54 6/4/2013 254.6 Euthanasia 
11 Trial 2 2528.0 0027 4/11/2013 5/31/2013 210.6 54 6/4/2013 243.6 HCN 
11 Trial 2 2528.0 0053 4/11/2013 5/31/2013 219.2 54 6/4/2013 251.6 HCN 
11 Trial 2 2528.0 0055 4/11/2013 5/31/2013 221.0 54 6/4/2013 259.1 Euthanasia 
11 Trial 2 2528.0 0081 4/11/2013 5/31/2013 217.4 54 6/4/2013 257.3 Euthanasia 
11 Trial 2 2528.0 0083 4/11/2013 5/31/2013 226.6 54 6/4/2013 265.0 Euthanasia 
11 Trial 2 2528.0 0185 4/11/2013 5/31/2013 233.0 54 6/4/2013 269.2 HCN 
11 Trial 2 2528.0 0187 4/11/2013 5/31/2013 214.5 54 6/4/2013 246.9 HCN 
11 Trial 2 2528.0 0209 4/11/2013 5/31/2013 224.6 54 6/4/2013 264.9 HCN 
11 Trial 2 2528.0 0211 4/11/2013 5/31/2013 225.9 54 6/4/2013 262.0 Euthanasia 
11 Trial 3 3175.0 0449 4/25/2013 6/14/2013 214.4 53 6/17/2013 239.6 HCN 
11 Trial 3 3175.0 0451 4/25/2013 6/14/2013 268.7 53 6/17/2013 304.4 HCN 
11 Trial 3 3175.0 0525 4/25/2013 6/14/2013 248.1 53 6/17/2013 279.8 HCN 
11 Trial 3 3175.0 0527 4/25/2013 6/14/2013 247.5 53 6/17/2013 278.9 HCN 
11 Trial 3 3175.0 0625 4/25/2013 6/14/2013 243.0 53 6/17/2013 273.8 HCN 
11 Trial 3 3175.0 0627 4/25/2013 6/14/2013 231.2 53 6/17/2013 256.5 HCN 
11 Trial 3 3175.0 0633 4/25/2013 6/14/2013 239.9 53 6/17/2013 270.6 HCN 
Profile 
(1-11) 
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11 Trial 3 3175.0 0635 4/25/2013 6/14/2013 246.2 53 6/17/2013 277.1 HCN 
11 Trial 3 3175.0 0637 4/25/2013 6/14/2013 251.4 53 6/17/2013 284.5 HCN 
11 Trial 3 3175.0 0639 4/25/2013 6/14/2013 268.1 53 6/17/2013 301.5 HCN 
11 Trial 4 2202.5 0477 4/25/2013 6/14/2013 209.5 56 6/20/2013 262.8 Euthanasia 
11 Trial 4 2202.5 0479 4/25/2013 6/14/2013 230.0 56 6/20/2013 294.1 HCN 
11 Trial 4 2202.5 0485 4/25/2013 6/14/2013 228.2 56 6/20/2013 285.4 Euthanasia 
11 Trial 4 2202.5 0487 4/25/2013 6/14/2013 216.2 56 6/20/2013 265.3 HCN 
11 Trial 4 2202.5 0609 4/25/2013 6/14/2013 229.1 56 6/20/2013 284.9 Euthanasia 
11 Trial 4 2202.5 0611 4/25/2013 6/14/2013 188.4 56 6/20/2013 226.6 HCN 
11 Trial 4 2202.5 0641 4/25/2013 6/14/2013 216.0 56 6/20/2013 277.5 HCN 
11 Trial 4 2202.5 0643 4/25/2013 6/14/2013 208.7 56 6/20/2013 260.8 HCN 
11 Trial 4 2202.5 0649 4/25/2013 6/14/2013 205.8 56 6/20/2013 254.2 HCN 
11 Trial 4 2202.5 0651 4/25/2013 6/14/2013 236.3 56 6/20/2013 299.5 HCN 
11 Trial 5 1793.2 0713 5/2/2013 6/21/2013 236.8 54 6/25/2013 275.7 Euthanasia 
11 Trial 5 1793.2 0715 5/2/2013 6/21/2013 238.1 54 6/25/2013 271.3 HCN 
11 Trial 5 1793.2 0753 5/2/2013 6/21/2013 251.7 54 6/25/2013 286.1 HCN 
(postexposure) 
11 Trial 5 1793.2 0755 5/2/2013 6/21/2013 227.7 54 6/25/2013 261.4 Euthanasia 
11 Trial 5 1793.2 0785 5/2/2013 6/21/2013 235.5 54 6/25/2013 268.9 HCN 
11 Trial 5 1793.2 0787 5/2/2013 6/21/2013 242.9 54 6/25/2013 281.3 Euthanasia 
11 Trial 5 1793.2 0853 5/2/2013 6/21/2013 238.6 54 6/25/2013 277.2 Euthanasia 
11 Trial 5 1793.2 0855 5/2/2013 6/21/2013 232.2 54 6/25/2013 264.0 HCN 
11 Trial 5 1793.2 0857 5/2/2013 6/21/2013 225.5 54 6/25/2013 251.9 Euthanasia 
11 Trial 5 1793.2 0859 5/2/2013 6/21/2013 250.6 54 6/25/2013 286.5 Euthanasia 
11 Trial 6 2186.3 0889 5/9/2013 6/28/2013 201.6 54 7/2/2013 233.0 HCN 
11 Trial 6 2186.3 0891 5/9/2013 6/28/2013 194.3 54 7/2/2013 226.9 HCN 
11 Trial 6 2186.3 0913 5/9/2013 6/28/2013 203.5 54 7/2/2013 235.3 HCN 
11 Trial 6 2186.3 0915 5/9/2013 6/28/2013 205.4 54 7/2/2013 241.3 HCN 
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11 Trial 6 2186.3 0921 5/9/2013 6/28/2013 207.5 54 7/2/2013 242.1 HCN 
11 Trial 6 2186.3 0923 5/9/2013 6/28/2013 214.7 54 7/2/2013 250.8 Euthanasia 
11 Trial 6 2186.3 0925 5/9/2013 6/28/2013 230.3 54 7/2/2013 263.1 HCN 
11 Trial 6 2186.3 0927 5/9/2013 6/28/2013 199.6 54 7/2/2013 230.2 HCN 
11 Trial 6 2186.3 0965 5/9/2013 6/28/2013 206.7 54 7/2/2013 246.9 HCN 
11 Trial 6 2186.3 0967 5/9/2013 6/28/2013 214.3 54 7/2/2013 258.4 HCN 
11 Trial 7 1597.5 1013 6/6/2013 7/26/2013 210.8 54 7/30/2013 241.3 Euthanasia 
11 Trial 7 1597.5 1015 6/6/2013 7/26/2013 217.3 54 7/30/2013 246.5 Euthanasia 
11 Trial 7 1597.5 1017 6/6/2013 7/26/2013 200.7 54 7/30/2013 233.2 Euthanasia 
11 Trial 7 1597.5 1019 6/6/2013 7/26/2013 222.0 54 7/30/2013 259.3 Euthanasia 
11 Trial 7 1597.5 1049 6/6/2013 7/26/2013 221.9 54 7/30/2013 260.6 Euthanasia 
11 Trial 7 1597.5 1051 6/6/2013 7/26/2013 217.9 54 7/30/2013 254.8 Euthanasia 
11 Trial 7 1597.5 1053 6/6/2013 7/26/2013 228.0 54 7/30/2013 266.3 Euthanasia 
11 Trial 7 1597.5 1055 6/6/2013 7/26/2013 215.4 54 7/30/2013 246.7 HCN 
11 Trial 7 1597.5 1093 6/6/2013 7/26/2013 225.2 54 7/30/2013 268.6 Euthanasia 
11 Trial 7 1597.5 1095 6/6/2013 7/26/2013 210.9 54 7/30/2013 247.0 Euthanasia 
a Animal 0309 (Profile 9, Trial 1) died following the 24 hour post-observation period, cause of death undetermined. 
Table S-3.  Animal Body Weights and Ages at Exposure (Mean ± standard deviation, range; 10 rats per trial) 
Profile Number 
of Trials 
Body weight (by 
individual) (g) 
Body weight (by 
trial mean) (g) 
Age at exposure (Days) 
1 5 263.4 ± 16.5 
(212.5 - 300.6) 
263.3 ± 9.3 
(254.7- 275.3) 
53.6 ± 0.5 (53-54) 
2 4 269.7 ± 12.8 
(246.2 – 297.3) 
269.6 ± 6.2 
(261.2 - 274.6) 
54.3 ± 1.3 (53-56) 
3 4 265.1 ± 17.2 
(220.6 – 292.3) 
265.1 ± 10.2 
(253.1 - 276.9) 
54.8 ± 0.4 (54-55) 
4 8 257.8 ± 17.7 
(211.8 – 294.4) 
257.9 ± 9.6 
(243.7 - 271.6) 
54.1 ± 1.1 (53-56) 
5 4 266.0 ± 16.5 
(212.7 – 291.5) 
266.0 ± 10.2 
(253.6 - 276.9) 
54.0 ± 1.0 (53-55) 
6 2 260.5 ± 14.5 
(227.0 - 281.5) 
260.5 ± 2.2 
(258.9 - 262.0) 
54.0 ± 1.0 (53-55) 
7 6 265.5 ± 18.0 
(219.7 - 303.6) 
265.5 ± 14.0 
(245.7 - 279.0) 
54.7 ± 1.3 (53-56) 
8 4 265.5 ± 13.8 
(237.1 – 297.7) 
265.5 ± 10.5 
(253.2 - 277.8) 
54.3 ± 0.4 (54-55) 
9 7 264.0 ± 13.9 
(227.9 – 294.5) 
264.0 ± 9.1 
(251.4 - 274.7) 
54.4 ± 1.4 (53-56) 
10 9 261.9 ± 19.2 
(211.9 – 320.0) 
261.9 ± 11.7 
(242.6 - 273.0) 
54.3 ± 0.9 (53-56) 
11 7 261.3 ± 19.1 
(226.6 – 304.4) 
261.3 ± 12.4 
(242.8 - 276.7) 
54.0 ± 0.9 (53-56) 
 
